Development and Validation of New RP-HPLC Method for the Simultaneous Determination of Codeine Phosphate and Triprolidine Hydrochloride in Cough Syrup Formulation by Suganya, K
DEVELOPMENT AND VALIDATION OF NEW RP-HPLC 
METHOD FOR THE SIMULTANEOUS DETERMINATION 
OF CODEINE PHOSPHATE AND TRIPROLIDINE 
HYDROCHLORIDE IN COUGH SYRUP FORMULATION 
 
Dissertation 
 
Submitted to  
 
THE TAMILNADU DR. M. G. R. MEDICAL UNIVERSITY,  
CHENNAI 
 
In Partial Fulfillment of the Requirements 
For the Award of Degree of 
 
 
MASTER OF PHARMACY 
IN 
PHARMACEUTICAL ANALYSIS 
 
 
DEPARTMENT OF PHARMACEUTICAL ANALYSIS 
K. M. COLLEGE OF PHARMACY, 
UTHANGUDI, MELUR MAIN ROAD, 
MADURAI - 625 107, TAMIL NADU. 
 
MAY – 2018 
  
This is to certify that the dissertation entitled "DEVELOPMENT AND 
VALIDATION OF NEW RP-HPLC METHOD FOR THE SIMULTANEOUS 
DETERMINATION OF CODEINE PHOSPHATE AND TRIPROLIDINE 
HYDROCHLORIDE IN COUGH SYRUP FORMULATION" Submitted by      
Ms. K. SUGANYA (Reg. No. 261630051) in partial fulfillment of the requirements for 
the award of degree of Master of Pharmacy in Pharmaceutical Analysis under    
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY, Chennai, done at   
K.M. COLLEGE OF PHARMACY, Uthangudi, Madurai. It is a bonafide work 
carried out by them under my guidance and direct supervision during the academic year 
of 2017 - 2018. This dissertation partially or fully has not been submitted for any other 
degree or diploma of this university or other universities.   
 
 
GUIDE PRINCIPAL 
  
Mr. D. Shankar, M. Pharm., DSM., (Ph.D.),     Dr. M. Sundarapandian, M. Pharm., Ph.D., 
Associate Professor & Research Coordinator,       Professor and HOD, 
Dept. of Pharmaceutical Analysis,                         Dept. of Pharmaceutical Analysis,                                 
K.M. College of Pharmacy,                                    K.M. College of Pharmacy, 
Uthangudi, Madurai - 625 107.                              Uthangudi, Madurai - 625 107. 
Tamil Nadu.                                                            Tamil Nadu. 
Certificate 
                                                           
 
ACKNOWLEDGEMENT 
 
Milestones in life are achieved, not by individual efforts but by blessings and 
guidance of elders, near and dear ones of collective wisdom and experience of all 
those who have shared their views for this dissertation is the product beyond those 
found within the covers of book. I therefore take this opportunity to express my 
acknowledgement to all of them. 
First and foremost I express my deepest sense of gratitude and faithfulness to 
God’s grace which has enabled me to finish my dissertation work successfully. It’s a 
dream come true for me to present this book, which has turned into a reality due to 
the blessings and prayers of a whole lot of people whom I am really grateful to. 
It is an honour to pay my heartfelt thanks to My Most Respected Founder 
Chairman Prof. M. Nagarajan, M. Pharm., M.B.A., DMS (IM)., DMS (BM).,           
K.M. College of  Pharmacy, Uthangudi, Madurai, for providing necessary facilities to 
carry out this dissertation work successfully. 
I also express my sincere thanks to Principal Dr. M. Sundarapandian,          
M. Pharm., Ph.D., Professor and HOD, Department of Pharmaceutical Analysis and 
Vice Principal Dr. N. Chidambaranathan, M. Pharm., Ph.D., Professor and HOD, 
Department of Pharmacology, K.M. College of Pharmacy, Uthangudi, Madurai, for 
their timely instigation and immeasurable esteemed help to complete this dissertation. 
Words are inadequate to express my extreme sense of gratitude and profound 
thanks to My Beloved Guide Mr. D. Shankar, M. Pharm., DSM., (Ph.D.),        
Associate Professor & Research Coordinator, Department of Pharmaceutical 
Analysis, K.M. College of Pharmacy, Uthangudi, Madurai. I am honoured to work 
under his precious guidance, encouragement and abundant help. His enthusiastic, 
inspiring discussion and timely suggestions which proved for the success of this work. 
                                                           
 
I wish to place my deep regards to Mr. P. Sakthivel, B. Pharm., Factory 
Manager, Pharmafabrikon, Unit-II, Vilathur, Madurai, Tamil Nadu, for his 
permission to carry out my dissertation work in their industry. 
My heartfelt thanks to Prof. M. S. Prakash, M. Pharm., Department of 
Pharmaceutical Analysis, K.M. College of Pharmacy, Uthangudi, Madurai, for his 
ideas and constant inspiration at every stage of my dissertation. 
I am also grateful to Mrs. M. Shobana, B. Pharm., Quality Control Manager, 
Mr. R. Balamurugan, M. Pharm., Quality Assurance Manager, Mr. J. Sivakumar,  
M. Sc., Quality Control Chemist and Mr. S. Rajkumar, M. Sc., Quality Control 
Chemist, Pharmafabrikon, Unit-II, Vilathur, Madurai, Tamil Nadu, for their excellent 
guidance throughout my dissertation work. 
My special thanks to Teaching and Non teaching staffs of K.M. College of 
Pharmacy, Uthangudi, Madurai, for their wishes and encouragement during my 
course. 
With deep sense of affection my express my endless gratitude to all               
My Friends who helped me in need, Thank you friends for your valuable help 
throughout my dissertation work. 
I pay tribute to My Father and Mother for lifting me up till this phase of life.  
I thank them for their love, trust, patience, support and bearing all kinds of stress to 
make me what I am. 
Finally, a word of thanks to all those gentle people associated with this work 
directly or indirectly whose names, I have been unable to mention here as they are 
like the countless stars in numerous galaxies. 
 
                                                  (K. SUGANYA) 
  
 
 
 
 
 
 
DEDICATED 
TO 
MY BELOVED 
 
PARENTS, GUIDE 
& FRIENDS 
 
                                                           
 
i 
LIST OF TABLES 
 
Table No. Name of the Table Page No. 
1 List of Instrumental Methods Vs Principle 3 
2 Common HPLC Solvents and their Properties 16 
3 Common HPLC Buffers and their Respective pKa 
and UV Cut-off Wavelength 
17 
4 System Suitability Parameters and 
Recommendations 
34 
5 List of Instruments Used 58 
6 List of Chemicals Used 58 
7 List of Active Pharmaceutical Ingredients Used 58 
8 Results of Trial:3 - Optimized Method (Codeine 
phosphate and Triprolidine hydrochloride) 
65 
9 Results of System Suitability (Codeine phosphate) 78 
10 Results of System Suitability (Triprolidine 
hydrochloride) 
79 
11 Results of Accuracy (50% Spike Solution) 80 
12 Results of Accuracy (100% Spike Solution) 80 
13 Results of Accuracy (150% Spike Solution) 81 
14 Results of Accuracy (Overall Mean, SD, % RSD 
for Codeine phosphate and Triprolidine 
hydrochloride) 
 
81 
                                                           
 
ii 
15 Results of % Recovery for Codeine phosphate and 
Triprolidine hydrochloride 
82 
16 Results of System Precision (Standard) 83 
17 Results of Method Precision (Sample - 1) 84 
18 Results of Method Precision (Sample - 2) 84 
19 Results of Method Precision (Sample - 3) 85 
20 Results of Method Precision (Sample - 4) 86 
21 Results of Method Precision (Sample - 5) 86 
22 Results of Method Precision (Sample - 6) 87 
23 Results of Method Precision (Overall Mean, SD, 
% RSD for Codeine phosphate and Triprolidine 
hydrochloride) 
87 
24 Results of Specificity (Standard - 1) 88 
25 Results of Specificity (Standard - 2) 89 
26 Results of Specificity (Standard - 3) 90 
27 Results of Specificity (Standard - 4) 90 
28 Results of Specificity (Standard - 5) 91 
29 Results of Specificity (Standard - 6) 92 
30 Results of Specificity (Overall Mean, SD, % RSD 
for Codeine phosphate and Triprolidine 
hydrochloride) 
92 
31 Results of Linearity - 1 (50 µg/ml) 93 
32 Results of Linearity - 2 (75 µg/ml) 94 
33 Results of Linearity - 3 (100 µg/ml) 94 
                                                           
 
iii 
34 Results of Linearity - 4 (125 µg/ml) 95 
35 Results of Linearity - 5 (150 µg/ml) 96 
36 Results of Linearity Level 1 - 5 (50 to 150 µg/ml) 
for Codeine phosphate 
97 
37 Results of Linearity Level 1 - 5 (50 to 150 µg/ml) 
for Triprolidne hydrochloride 
98 
38 Results of Robustness - Standard Solution 1  
(Flow Rate - 1.2 ml/min) 
99 
39 Results of Robustness - Standard Solution 2  
(Flow Rate - 1.2 ml/min) 
100 
40 Results of Robustness - Standard Solution 3  
(Flow Rate - 1.2 ml/min) 
100 
41 Results of Robustness - Standard Solution 4  
(Flow Rate - 1.2 ml/min) 
101 
42 Results of Robustness - Standard Solution 5  
(Flow Rate - 1.2 ml/min) 
102 
43 Results of Robustness - Standard Solution 1  
(Flow Rate - 1.4 ml/min) 
102 
44 Results of Robustness - Standard Solution 2  
(Flow Rate - 1.4 ml/min) 
103 
45 Results of Robustness - Standard Solution 3  
(Flow Rate - 1.4 ml/min) 
104 
46 Results of Robustness - Standard Solution 4  
(Flow Rate - 1.4 ml/min) 
104 
47 Results of Robustness - Standard Solution 5  
(Flow Rate - 1.4 ml/min) 
105 
                                                           
 
iv 
48 Results of Robustness - Standard Solution        
(pH - 2.2) 
106 
49 Results of Robustness - Standard Solution        
(pH - 2.4) 
106 
50 Results of Robustness - Flow Rate 
Variation/Standard Solution 1 to 5 (Overall Mean, 
SD, % RSD for Codeine phosphate and 
Triprolidine hydrochloride) 
107 
51 Results of Ruggedness - Day 1 (Analyst - 1) for 
Codeine phosphate and Triprolidine hydrochloride 
108 
52 Results of Ruggedness - Day 2 (Analyst - 2) for 
Codeine phosphate and Triprolidine hydrochloride 
109 
53 Results of Ruggedness - Day 1 & 2 (Analyst - 1) 
for Codeine phosphate and Triprolidine 
hydrochloride 
109 
54 Results of Ruggedness - Day 1 & 2 (Analyst - 2) 
for Codeine phosphate and Triprolidine 
hydrochloride 
110 
55 Validation Summary 113 
 
 
                                                           
 
v 
LIST OF FIGURES 
 
Figure No. Name of the Figure Page No. 
1 Block Diagram of Analytical Instruments Showing 
the Stimulus and Measurements of Response 
2 
2 Classification of Chromatography 8 
3 Preparative HPLC Apparatus 9 
4 Normal Phase Chromatography 11 
5 Reverse Phase Chromatography 11 
6 Ion Exchange Chromatography 12 
7 Size Exclusion Chromatography 12 
8 Components of High Performance Liquid 
Chromatography 
15 
9 Reciprocating Pump 18 
10 Injector 20 
11 Chromatogram of Trial:1 (Codeine phosphate and 
Triprolidine hydrochloride) 
62 
12 Chromatogram of Trial:2 (Codeine phosphate and 
Triprolidine hydrochloride) 
63 
13 Chromatogram of Trial:3 - Optimized Method 
(Codeine phosphate and Triprolidine 
hydrochloride) 
64 
14 Chromatogram of System Suitability 78 
15 Chromatogram of Accuracy (50% Spike Solution) 79 
                                                           
 
vi 
16 Chromatogram of Accuracy (100% Spike Solution) 80 
17 Chromatogram of Accuracy (150% Spike Solution) 81 
18 Chromatogram of Precision (Blank) 82 
19 Chromatogram of System Precision (Standard) 83 
20 Chromatogram of Method Precision (Sample - 1) 83 
21 Chromatogram of Method Precision (Sample - 2) 84 
22 Chromatogram of Method Precision (Sample - 3) 85 
23 Chromatogram of Method Precision (Sample - 4) 85 
24 Chromatogram of Method Precision (Sample - 5) 86 
25 Chromatogram of Method Precision (Sample - 6) 87 
26 Chromatogram of Specificity (Blank) 88 
27 Chromatogram of Specificity (Standard - 1) 88 
28 Chromatogram of Specificity (Standard - 2) 89 
29 Chromatogram of Specificity (Standard - 3) 89 
30 Chromatogram of Specificity (Standard - 4) 90 
31 Chromatogram of Specificity (Standard - 5) 91 
32 Chromatogram of Specificity (Standard - 6) 91 
33 Chromatogram of Linearity - 1 (50 µg/ml) 93 
34 Chromatogram of Linearity - 2 (75 µg/ml) 93 
35 Chromatogram of Linearity - 3 (100 µg/ml) 94 
36 Chromatogram of Linearity - 4 (125 µg/ml) 95 
37 Chromatogram of Linearity - 5 (150 µg/ml) 95 
                                                           
 
vii 
38 Chromatogram of Overlay of Linearity 1 - 5      
(50 to 150 µg/ml) 
96 
39 Chromatogram of Linearity Level 1 - 5        
(50 to 150 µg/ml) for Codeine phosphate 
96 
40 Chromatogram of Linearity Level 1 - 5                
(50 to 150 µg/ml) for Triprolidne hydrochloride 
97 
41 Chromatogram of Robustness (Blank) 98 
42 Chromatogram of Robustness - Standard Solution 1 
(Flow Rate - 1.2 ml/min) 
99 
43 Chromatogram of Robustness - Standard Solution 2 
(Flow Rate - 1.2 ml/min) 
99 
44 Chromatogram of Robustness - Standard Solution 3 
(Flow Rate - 1.2 ml/min) 
100 
45 Chromatogram of Robustness - Standard Solution 4 
(Flow Rate - 1.2 ml/min) 
101 
46 Chromatogram of Robustness - Standard Solution 5 
(Flow Rate - 1.2 ml/min) 
101 
47 Chromatogram of Robustness - Standard Solution 1 
(Flow Rate - 1.4 ml/min) 
102 
48 Chromatogram of Robustness - Standard Solution 2 
(Flow Rate - 1.4 ml/min) 
103 
49 Chromatogram of Robustness - Standard Solution 3 
(Flow Rate - 1.4 ml/min) 
103 
50 Chromatogram of Robustness - Standard Solution 4 
(Flow Rate - 1.4 ml/min) 
 
104 
                                                           
 
viii 
51 Chromatogram of Robustness - Standard Solution 5 
(Flow Rate - 1.4 ml/min) 
105 
52 Chromatogram of Robustness - Standard Solution 
(pH - 2.2) 
105 
53 Chromatogram of Robustness - Standard Solution 
(pH - 2.4) 
106 
54 Chromatogram of Ruggedness (Blank) 108 
55 Chromatogram of Ruggedness - Day 1 (Analyst - 1) 
for Codeine phosphate and Triprolidine 
hydrochloride 
108 
56 Chromatogram of Ruggedness - Day 2 (Analyst - 2) 
for Codeine phosphate and Triprolidine 
hydrochloride 
109 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                           
 
ix 
 LIST OF ABBREVIATIONS 
 
    HPLC    :  High Performance Liquid Chromatography 
    LC   :  Liquid Chromatography 
    RP-HPLC  :  Reverse Phase High Performance Liquid    
Chromatography 
    UV   :  Ultra Violet 
    MS   : Mass Spectrometry 
    NMR  : Nuclear Magnetic Resonance 
    IR   : Infra Red 
    ESR  : Electron Spin Resonance 
    ELSD  : Evaporative Light Scattering Detector 
    RSD  :  Relative Standard Deviation     
    N   : Number of Theoretical Plates   
    SD   :  Standard Deviation 
    NMT  : Not More Then 
    NLT  : Not Less Then    
    K’   : Capacity Factor 
    RS   : Resolution  
    T   : Tailing Factor       
    nm   :  Nanometer 
    mm   :  Millimeter 
    mg   : Milligram 
    ml   :  Milliliter 
    mM   : Millimolar 
    µl   :  Microliter 
                                                           
 
x 
    µg   : Microgram        
    µm   :  Micrometer  
    µ                          :  Micron 
    ºC                        :  Degree Centigrade 
    RP                 :  Reverse Phase 
    pH   : Hydrogen ion Concentration  
    PDA  : Photo Diode Array        
    tR or RT  : Retention Time 
    vR      : Retention Volume 
    S. No.  :  Serial Number 
    v/v      :  Volume/Volume 
    %       :           Percentage 
    Sec      :           Second 
    Min                     :  Minute 
    RH   : Relative Humidity  
    RI : Refractive Index 
    CP : Codeine Phosphate 
    TH : Triprolidine Hydrochloride 
    e.g. : Example 
    USP                     :  United States of Pharmacopoeia  
    FDA  :  Food Drug Administration  
    API   : Active Pharmaceutical Ingredient     
    ICH : International Conference of Hormonization  
 
                                                           
 
INDEX 
 
Chapter No. Contents Page No. 
 List of Tables i 
 List of Figures v 
 List of Abbreviations ix 
I Introduction 1 
II Drug Profile 39 
III Literature Review 44 
IV Aims and Objectives 57 
V Instruments and Chemicals 58 
VI Method Development 59 
VII Method Validation 66 
VIII Results and Discussion 78 
IX Summary and Conclusion 111 
X Bibliography 115 
 
CHAPTER - I                                                                                           Introduction                                                                                   
 
1 
CHAPTER - I 
 
INTRODUCTION 
 
1.1 Pharmaceutical Analysis: 
 Pharmaceutical analysis is the branch of science which deals with identification 
of substances and determination of amount present in particular sample. Also 
pharmaceutical analysis deals with bulk materials, dosage forms and more 
recently, biological samples in support of Bio-pharmaceutical and 
Pharmacokinetic studies. 
 Analysis can be divided into areas called qualitative and quantitative analysis. 
Pharmaceutical products synthesized and identified using Instrumental 
Techniques.
1 
These methods are used extensively in the qualitative assurance of 
raw materials, in process quality assessment, stability of the drugs on storage 
monitoring drugs concentrations in various body fluids or tissues. 
The types of analysis can be distinguished in two ways: 
a. Qualitative Analysis:                                                                                                 
To refer identity of product, i.e., it yields useful clue from which the molecular 
or atomic species, the structural features or the functional groups in the sample can be 
identified. 
b. Quantitative Analysis:                                                                                           
To refer the purity of the product, i.e., the results are in the form of     
numerical data corresponding to the concentration of analytes.             
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1.2 Types of Analytical Methods: 
The various methods of analysis 
2
 can be grouped into two categories namely             
  a. Chemical Methods   
  b. Instrumental Methods 
a. Chemical Methods: 
In these methods, volume and mass are used as means of detection. 
 Titrimetrical methods like acid-base, oxidation-reduction,          
non-aqueous, complexometric and precipitation titrations 
 Gravimetric and thermo gravimetric methods 
 Volumetric methods 
b. Instrumental Methods: 
These methods are based on the measurement of specific and non-specific 
physical properties of substances. The Block diagram of analytical instruments 
3
 and 
different instrumental methods based on principle are shown in Figure No. 1 and     
Table No. 1 repectively.    
 
Figure No. 1. Block Diagram of Analytical Instruments Showing 
            the Stimulus and Measurements of Response 
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Table No. 1. List of Instrumental Methods Vs Principle 
S. No. Principle Instrumental Methods 
1 Emission of Radiation X-ray Emission Spectrometry            
and Fluorescence Spectrometry 
2 Absorption of Radiation UV/Visible Spectrophotometry,             
NMR and IR Spectrometry,                      
ESR Spectroscopy and                                
Atomic Absorption Spectrometry 
3 Mass to Charge Ratio Mass Spectrometry (MS) 
4 Refraction of  Radiation Refractometry 
5 Scattering of  Radiation Nephelometry 
6 Rotation of Radiation Polarimetry 
7 Electrical Potential Potentiometry 
8 Electrical Current Amperometry and Polarography 
9 Electrical Resistance Conductometry 
10 Thermal Properties Differential Thermal Analysis,      
Differential Scanning Calorimetry             
and Thermogravimetry 
11 Partition/Adsorption Chromatographic Techniques 
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1.3 Chromatography: 
4
 
 Chromatography (from Greek chroma, color and graphein to write) is the 
collective term for a set of laboratory techniques for the separation of mixtures. It 
involves passing a mixture dissolved in a “Mobile Phase” through a stationary 
phase, which separates the analyte to be measured from other molecules in the 
mixture based on differential partitioning between the mobile and stationary 
phase. Subtle differences in a compound’s partition coefficient result in 
differential retention on the stationary phase and thus changing the separation. 
 Chromatography may be preparative or analytical. The purpose of preparative 
chromatography is to separate the component of a mixture for further use (and is 
thus a form of purification). Analytical chromatography is done normally with 
smaller amounts of material and is for measuring the relative proportions of 
analytes in a mixture. 
 The two are not mutually exclusive. The history of chromatography begins during 
the mid-19
th
 century. Chromatography, literally “color writing”, was used and 
named in the first decade of the 20
th
 century, primarily for the separation of plant 
pigments such as chlorophyll.  
 New type of chromatography developed during the 1930s And 1940s made the 
technique useful for many types of separation process. Some related techniques 
were developed during the 19
th
 century (and even before), but the first true 
chromatography.                    
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1.3a Chromatographic Terms: 
 The analyte is the substance to be separated during chromatography. 
 Analytical chromatography is used to determine the existence and possibly 
also the concentration of analyte (s) in a sample. 
 A bonded phase is a stationary phase that is covalently bonded to the support 
particles or to the inside wall of the column tubing. 
 A chromatogram is the visual output of the chromatograph. In the case of an 
optimal separation, different peaks or patterns on the chromatogram 
correspond to different components of the separated mixture. Plotted on the  
x-axis is the retention time and plotted on the y-axis a signal (for example 
obtained by a spectrophotometer, mass spectrometer or a variety of other 
detectors) corresponding to the response created by the analytics exiting the 
system. In the case of an optimal system the signal is proportional to the     
concentration of the specific analytes separated. 
 A chromatograh is equipment that enables a sophisticated separation e.g. gas 
chromatographic or liquid chromatographic separation. 
 Chromatography is a physical method of separation in which the compounds 
to be separated are distributed between two phases, one of which is stationary 
(stationary phase) while the other (mobile phase) moves in a definite direction. 
 The eluent is the mobile phase leaving the column. 
 An eluotropic series is a list of solvents ranked according to their eluting 
power. 
 An immobilized phase is stationary phase which immobilized support 
particles, or on the inner wall of the column tubing. 
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 The mobile phase is the phase that moves in a definite direction. It may be a 
liquid (Liquid Chromatography, Capillary Electro Chromatography, Gas 
Chromatography and Supercritical Fluid Chromatography). The mobile phase 
consists of the sample being separated and the solvent that moves the sample 
through the column. In the case of HPLC the normal phase or polar solvents in 
reverse phase moves through the chromatography column where the sample 
interacts with the stationary phase and is separated. 
 Preparative chromatography is used to purify sufficient quantities of a 
substance for further use, rather than analysis. 
 The retention time is the characteristic time it takes for a particular analyte to 
pass through the system (from the column inlet to the detector) under set 
conditions. 
 The sample is the matter analyzed in chromatography. It may consist of a 
single component or it may be a mixture of components. 
 The solute refers to the sample components in partition chromatography. 
 The solvent refers to any substance capable of solubilizing another substance, 
and especially the liquid mobile phase in liquid chromatograph. 
 The stationary phase is the substance fixed in place for the chromatography 
procedure. Example includes the silica layer in thin layer chromatography. 
 The detector refers to the instrument used for qualitative and quantitative 
detection of analytes after separation.  
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1.3b Types of Chromatography: 
Chromatography can be classified into many types are shown in Figure No. 2.  
 Based upon the nature of stationary and mobile phase: 
 Gas-Solid Chromatography 
 Gas-Liquid Chromatography 
 Solid-Liquid Chromatography 
 Liquid-Liquid Chromatography 
 Based on the principle of separation: 
 Adsorption Chromatography 
 e.g. Gas-Solid Chromatography, Thin Layer Chromatography, Column   
Chromatography and High Performance Liquid Chromatography 
(HPLC) 
 Partition Chromatography 
   e.g. Gas-Liquid Chromatography, Paper Chromatography,  
         Column Chromatography 
 Based on the modes of chromatography: 
 Normal Phase Chromatography 
 Reverse Phase Chromatography 
 Other types of chromatography: 
 Ion Exchange Chromatography 
 Gel Permeation Chromatography 
 Chiral Chromatography 
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Figure No. 2. Classification of Chromatography 
 
1.4 High Performance Liquid Chromatography (HPLC): 
 Initially, pressure was selected as the principal criterion of modern liquid 
chromatography and thus the name was "High Pressure Liquid Chromatography" 
or HPLC. This was, however, an unfortunate term because it seems to indicate 
that the improved performance is primarily due to the high pressure. This is, 
however, not true. In fact, high performance is the result of many factors: Very 
small particles of narrow distribution range and uniform pore size and 
distribution, high pressure column slurry packing techniques, accurate low 
volume sample injectors, and sensitive low volume detectors and, of course, good 
pumping systems. Naturally, pressure is needed to permit a given flow rate of the 
mobile phase. 
 High Performance Liquid Chromatography (HPLC) is a versatile analytical 
technology widely used for the analysis of pharmaceuticals, biomolecules, 
polymers and many organic and ionic compounds. The preparative HPLC 
apparatus are shown in Figure No. 3. 
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Figure No. 3. Preparative HPLC Apparatus 
 
1.4a Types of HPLC Techniques: 
A) Based on Modes of Separation   
 Normal Phase Chromatography 
 Reversed Phase Chromatography 
B) Based on Principle of Separation 
 Adsorption Chromatography  
 Ion Exchange Chromatography  
 Size Exclusion or Gel Permeation Chromatography  
 Affinity Chromatography  
 Chiral Phase Chromatography 
C) Based on Elution Techniques  
 Isocratic Separation 
 Gradient Separation  
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D) Based on the Scale of Operation  
 Analytical HPLC 
 Preparative HPLC  
E) Based on the Type of Analysis 
 Qualitative Analysis 
 Quantitative Analysis  
A) Based on Modes of Separation:  
 There are two modes of chromatography viz-normal phase mode and reverse 
phase mode. These modes are based on the polarity of stationary and mobile 
phase. Before explaining the modes, it is important to know the interactions 
which occur between solute, stationary and mobile phase. 
 Polar-Polar   -     Interaction or affinity is more 
 Nonpolar-Nonpolar  -     Interaction or affinity is more 
 Polar-Nonpolar  -     Interaction or affinity is less 
 Normal Phase Chromatography:  
In normal phase mode, the stationary phase is polar in nature and the 
mobile phase is non polar (Figure No. 4). In this technique, non-polar 
compounds travel faster and are eluted first. This is because of less affinity 
between solute and stationary phase. Polar compounds are retained for longer 
time in the column because of more affinity towards stationary phase and take 
more time to be eluted from the column. This is not advantageous in 
pharmaceutical applications since most of the drug molecules are polar in 
nature and takes longer time to be eluted and detected. 
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Figure No. 4. Normal Phase Chromatography 
 
 Reverse Phase Chromatography:  
In reverse phase mode, the stationary phase is non polar in nature and 
the mobile phase is polar (Figure No. 5). Hence polar components get eluted 
first and non-polar compounds are retained for a longer time. Since most of 
the drugs are polar in nature, they are not retained for a longer time and eluted 
faster, which is advantageous. 
Figure No. 5. Reverse Phase Chromatography 
 
B) Based on Principle of Separation: 
 Adsorption Chromatography: 
    The principle of separation is adsorption. Separation of components 
takes place because of the difference in affinity of compounds towards 
stationary phase. 
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 Ion Exchange Chromatography: 
 The principle of separation is ion exchange, which is reversible 
exchange of functional groups. In ion exchange resin is used to separate a 
mixture of similar charged ions. Typical stationary phases are cationic 
exchange (Sulfonate) or anionic exchange (quaternary ammonium) groups 
bonded to polymeric or silica materials (Figure No. 6). Mobile phases consist 
of buffers, often with increasing ionic strength, to force the migration of the 
analytes. 
Figure No. 6. Ion Exchange Chromatography 
 
 Size Exclusion or Gel Permeation Chromatography: 
     In this type of chromatography, a mixture of components with different 
molecular sizes is separated by using gels (Figure No. 7). 
Figure No. 7. Size Exclusion Chromatography 
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 Affinity Chromatography: 
 This uses the affinity of the sample with specific stationary phases. 
This technique is mostly used in the field of biotechnology, microbiology and 
biochemistry. 
 Chiral Phase Chromatography: 
This technique involves the separation of optical isomers can be done 
by using chiral stationary phases. 
C) Based on Elution Techniques: 
  Isocratic Separation:  
In this the same mobile phase combination is used throughout the 
process of separation. 
  Gradient Separation:  
In this a mobile phase combination of lower polarity is used followed 
by gradually increasing the polarity. 
D) Based on the Scale of Operation: 
 Analytical HPLC:  
Where only analysis of the samples can be done. Recovery of the 
samples for reusing is not done, since the sample used is very low. 
 Preparative HPLC:  
Where the individual fractions of pure compounds can be collected 
using fraction collector. The collected samples are reused. 
E) Based on the Type of Analysis: 
 Qualitative Analysis: 
  This is used to identify the compound, detect the presence of impurities,                                                                                
to find the number of components. This is done by using retention time values.  
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 Quantitative Analysis:  
This is done to determine the quantity of the individual or several 
components in a mixture. This is done by comparing the peak area of the 
standard and sample. 
1.4b Instrumentation of HPLC: 
5
 
 HPLC instrumentation includes a pump, injector, column, detector and data 
system (Figure No. 8). The heart of the system is the column where separation 
occurs. Since the stationary phase is composed of micrometer size porous 
particles, a high pressure pump is required to move the mobile phase through the 
column. The chromatographic process begins by injecting the solute onto the top 
of the column. Separation of components occurs as the analytes and mobile phase 
are pumped through the column. Eventually, each component elutes from the 
column as a narrow band (or Peak) on the recorder. 
 Detection of the eluting components is important, and this can be either selective 
or universal, depending upon the detector used. The response of the detector to 
each component is displayed on a chart recorder or computer screen and is known 
as a chromatogram. To collect, store and analyse the chromatographic data, 
computer, integrator and other data processing equipment are frequently used.  
 The Main Components of HPLC are: 
a) Solvent Reservoir 
b) Pump 
c) Injection Port 
d) Column 
e) Detector 
f) Data Acquisition System  
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Figure No. 8. Components of High Performance Liquid Chromatography 
 
 
a) Solvent Reservoir: 
Solvent Reservoir is used to store mobile phase. Scott Duran bottles are 
commonly used as solvent reservoirs. The solvent reservoir must be made of inert 
material such as glass and must be smooth so as to avoid growth of microorganisms 
on its walls. It can be transparent or can be amber colored. A graduated bittle gives a 
rough estimate of mobile phase volume in the bottle. Solvent reservoirs are placed 
above HPLC system (at higher level) in a tray. They should never keep directly above 
the system as any spillage of solvent on the system may damage electronic parts of 
HPLC. 
   Mobile Phase: 
The power of HPLC in terms of being able to resolve many compounds is 
mainly due to the diversity of mobile phase or mobile solvents available. The mobile 
phase in HPLC, however, has a great influence on the retention of the solutes and the 
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separation of component mixtures. Table No. 2 summarizes the commonly used 
HPLC solvents and their properties. 
Table No. 2. Common HPLC Solvents and their Properties 
 
Ideally, solvents used as HPLC mobile phases should have these 
characteristics: 
 High solubility for the sample components 
 Non corrosive to HPLC system components 
 High purity, low cost and UV transparency 
 Other desirable characteristics include low viscosity, low toxicity and non 
ﬂammability.  
 Buffers: 
The pH of the aqueous component in the mobile phase can have a dramatic 
effect on the retention of ionizable (acidic or basic) analytes. In RP-HPLC, the 
ionized form of the solute does not partition well into the hydrophobic stationary 
phase and has signiﬁcantly lower pKa than the neutral form. Buffers are required to 
control the pH of the mobile phase. Table No. 3 summarizes the commonly used 
HPLC buffers and their respective pKa and UV cut-off wavelength. 
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Table No. 3. Common HPLC Buffers and their Respective  
 pKa and UV Cut-off Wavelength 
 
 
 
 
 
 
 
 
 
 
 
b) Pump: 
 The HPLC pump is very important in component of the system. The pump 
delivers the constant flow of the mobile phase so that the separation of the 
components of the mixture occurs in a reasonable time. There are two types of 
pumping systems namely Isocratic and Gradient. The gradient type of pumps also 
classified into two types, those are: 
 High pressure mixing, e.g. Mechanical and Piston pumps      
 Low pressure mixing, e.g. Pneumatic and Quaternary pumps     
Modern pumps have the following parameters:   
 Flow rate range: 0.01 to 5 ml/min   
 Flow rate stability: NMT 1%    
 For SEC flow rate stability should be less than 0.2%   
 Maximum pressure: up to 3000 psi   
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There are three types of pumps commonly used: 
 Reciprocating Pump: 
 Reciprocating pumps usually consist of a small chamber in which the solvent 
is pumped by the back and forth motion of a motor driven piston. Two check valves 
control the flow of solvent. Reciprocating pumps (Figure No. 9) have a disadvantage 
of producing pulsed flow, which must be damped as its presence is manifested as base 
line noise on the chromatogram. Advantages of this pump include their small internal 
volume, high output pressure, ready adaptability to gradient elution and independent 
of column backpressure and viscosity of solvent. 
Figure No. 9. Reciprocating Pump 
 
 Displacement Pump: 
 Displacement pumps usually consist of large syringe like chambers equipped 
with a plunger that is activated by a screw driven mechanism powered by stepping 
motor. Displacement pumps also produce a flow that tends to be independent of 
viscosity and backpressure. In addition, the output is pulse free. Disadvantages 
include limited solvent capacity (250 ml) and considerable inconvenience when 
solvents must be changed. 
 Pneumatic Pump: 
In pneumatic pumps, the mobile phase is contained in a collapsible container 
housed in a vessel that can be pressurized by a compressor gas. Pumps of this kind are 
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inexpensive and pulse free. They suffer from limited capacity, pressure output, 
dependence of flow rate on solvent viscosity and column backpressure. In addition, 
they are not amenable to gradient elution and are limited to pressures less than about 
2000 psi. 
c) Injection Port: 
6
 
 Sample introduction can be accomplished in various ways. The simplest method 
is to use an injection valve. In more sophisticated LC systems, automatic 
sampling devices are incorporated where the sample is introduced with the help 
of auto samplers and microprocessors.  In liquid chromatography, liquid samples 
may be injected directly and solid samples need only be dissolved in an 
appropriate solvent. The solvent need not be the mobile phase, but frequently it is 
judiciously chosen to avoid detector interference, column/component 
interference, and loss in efficiency or all of these. 
 It is always best to remove particles from the sample by filtering over a 5 µm 
filter or centrifuging, since continuous injections of particulate material will 
eventually cause blockages in injection devices or columns. Sample sizes may 
vary widely. The availability of highly sensitive detectors frequently allows use 
of the small samples which yield the highest column performance. 
 The most widely used sample injection system is loop injection valve. These 
valves provide precise injection volumes against high-pressures. In this sample 
load mode, the sample is flushed through the sample loop with the excess going 
to the drain. For sample is flushed through the sample loop with excess going to 
the drain. For sample injection, the valves are rotated so that the mobile phase 
flows through the sample loop flushing the sample to column. Precision of the 
sample injection using the loop injector may be as good as 0.1% RSD. 
CHAPTER - I                                                                                           Introduction                                                                                   
 
20 
 In Rheodyne 7125 valve (Figure No. 10), sample from a microlitre syringe is 
loaded into the needle port, filling the sample loop, which is a small piece of 
stainless steel tube connected between ports. Any excess goes to waste from 
another port. On turning to ‘inject’, the loop contents are flushed on to the 
column. A variety of loop volumes is available, commonly 10-50 µl. 
Figure No. 10. Injector 
 
 
d) Column: 
7
 
 Typical HPLC columns are 5, 10, 15 and 25 cm in length and are filled with 
small diameter (3, 5 or 10 µm) particles. The internal diameter of the columns are 
usually 4.6 mm; this is considered the best compromise for sample capacity, 
mobile phase consumption, speed and resolution. However, if pure substances are 
to be collected (preparative scale), then larger diameter columns may be needed. 
 Packing the column tubing with small diameter particles requires high skill and 
specialized equipment. For this reason, it is generally recommended that all but 
the most experienced chromatographers purchase prepacked columns, since it is 
difficult to match the high performance of professionally packed LC columns 
without a large investment in time and equipment. 
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 In general, LC columns are fairly durable and one can expect a long service life 
unless they are used in some manner which is intrinsically destructive, as for e.g. 
with highly acidic or basic eluents, or with continual injections of 'dirty' 
biological or crude samples.  
There are three types of columns namely: 
 Analytical columns 
 Preparative columns 
 Guard columns 
Column Packing Materials (Adsorbents):   
 In liquid-liquid chromatography the stationary phase is a liquid film coated on a 
packing material consisting of 3-10 µm porous silica particles. The stationary 
phase may be partially soluble in the mobile phase, causing it to “bleed” from the 
column over time. To prevent this loss of stationary phase, it is covalently bound 
to the silica particles. Bonded stationary phases are attached by reacting the silica 
particles with an organochlorosilane of the general form Si(CH3)2RCl, where R is 
an alkyl or substituted alkyl group. 
 
 To prevent unwanted interactions between the solutes and any unreacted –SiOH 
groups, the silica frequently is “capped” by reacting it with Si(CH3)3Cl; such 
columns are designated as end-capped. 
 The properties of a stationary phase are determined by the nature of the 
organosilane alkyl group. If R is a polar functional group, then the stationary 
phase will be polar. Examples of polar stationary phases include those for which 
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R contains a cyano (–C2H4CN), diol (–C3H6OCH2CHOHCH2OH), or amino       
(–C3H6NH2) functional group. Since the stationary phase is polar, the mobile 
phase is a nonpolar or moderately polar solvent. The combination of a polar 
stationary phase and a nonpolar mobile phase is called normal-phase 
chromatography.  
 In reverse-phase chromatography, which is the more commonly encountered 
form of HPLC, the stationary phase is nonpolar and the mobile phase is polar. 
The most common nonpolar stationary phases use an organochlorosilane for 
which the R group is an n-octyl (C8) or n-octyldecyl (C18) hydrocarbon chain. 
Most reverse-phase separations are carried out using a buffered aqueous solution 
as a polar mobile phase. Because the silica substrate is subject to hydrolysis in 
basic solutions, the pH of the mobile phase must be less than 7.5. 
e) Detector: 
8 
 Detectors detect various compounds as they elute out from column. The detector 
gives response in terms of a milivolt (mv) signal that is then processed by the 
computer (integrator) to obtain you a chromatogram. Basically detector consists 
of a flow cell through which the mobile phase and resolved. Sample moves optic 
shine through the detector cell and variation in optical properties are detected. 
Various types of HPLC detector: 
 UV-Visible detector 
 Photo diode array detector (PDA) 
 Fluorescence detector 
 Conductometric and colorimetric detector 
 Mass detector 
 Evaporative light scattering detector (ELSD)   
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 Among these detector, photo diode array detector (PDA) is the most used 
detector in LC today. The PDA gives a three dimensional view of chromatogram 
(intensity Vs time) and spectra (intensity Vs wavelength) simultaneously. It can 
be called as Spectro- chromatogram. The detailed analysis of the data reveals 
more information on the complexity of coelution and helps in identifying the 
merged peaks and gives information on peak purity. 
Ideal characteristics of a detector: 
 Either is equally sensitive to all eluted peaks. 
 The ideal detector give the response (area) proportional to the amount 
injected, irrespective of the size of sample. 
 Cheap, reliable and easy to use. 
 Should not be affected by change in temperature or mobile phase 
composition. 
 It should be able to monitor small amount of compound. 
f) Data Acquisition System: 
 Since the detector signal is electronic, using modern data collection techniques 
can aid the signal analysis. In addition, some systems can store data in a 
retrievable form for highly sophisticated computer analysis at a later time. The 
main goal is using electronic data system is to increase analysis accuracy and 
precision, while reducing operator attention.  
 There are several types of data systems, each differing in terms of available 
features. In routine analysis, where no automation (in terms of data management 
or process control) is needed, a pre-programmed computing integrator may be 
sufficient. If higher control levels are desired, a more intelligent device is 
necessary, such as a data station or minicomputer. The advantages of intelligent 
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processors in chromatographs are found in several areas. First, additional 
automation options become easier to implement. Second, complex data analysis 
becomes more feasible. These analysis options include such features as run 
parameter optimisation and deconvolution (i.e. resolution) of overlapping peaks. 
Finally, software safeguards can be designed to reduce accidental misuse of the 
system. 
1.5 Chromatography Parameters: 
9
 
 Retention Time (tR): 
The time between the sample injection and the peak maximum is called 
retention time. Retention time is measured in minutes or seconds. 
 Retention Volume (vR): 
Retention volume is the volume of mobile phase required to elute 50% of the 
component from the column. It is the product of retention time and flow rate. 
vR = Retention time (tR) x Flow rate 
 Resolution (RS): 
Resolution (Rs) is a measure of the degree of separation of two adjacent 
analytes. Rs is deﬁned as the difference in retention time of the two peaks divided by 
the average peak width. 
 
Where,                                      
tR1 and tR2 = Retention time or baseline distances between the  
point of injection and the perpendicular dropped 
from the maximum of each of the two peaks 
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Wb1 and Wb2  = Respective peak widths determined at half peak  
height, measured in the same units as tR1 and tR2 
 Column Efficiency (N): 
It is called as the number of theoretical plates (N). It is a measure of the 
efficiency of the column. If the number of theoretical plates is high, the column is said 
to be highly efficient. If the number of theoretical plates is low, the column is said to 
be less efficient.    
Number of theoretical plates, N =  
 Tailing Factor (T): 
The tailing factor T, a measure of peak symmetry is unity for perfectly 
symmetrical peaks and its value increases as tailing becomes more pronounced. In 
some cases, values less than one may be observed. As peak asymmetry increases 
integration and hence precision becomes less reliable. 
T =  W 0.05/2f 
Where, 
              W 0.05     =  Width of peak at 5% height 
                      f    =   Distance from the peak maximum to the leading  
edge of the peak, the distance being measured at  
a point 5% of the peak height from the baseline 
 Peak Symmetry: 
  The peak symmetry can be represented in terms of peak asymmetry factor 
which can be calculated by using the following formula: 
Peak asymmetry factor = B/A 
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Where, 
   B   =  The distance at 50% peak height between leading edge  
    to the perpendicular drawn from the peak maxima 
   A   =  The width of the peak at half of the peak height 
1.6 Method Development: 
10
 
 The number of drugs introduced into the market is increasing every year. These 
drugs may be either new entities or partial structural modification of the exiting 
one. Very often there is a time lag from the date of introduction of a drug into the 
market to the date of its inclusion in pharmacopoeias.  
 This happens because of the possible uncertainties in the continuous and wider 
usage of these drugs, reports of new toxicities (resulting in their withdrawal from 
the market), Development of patient resistance and introduction of better drugs 
by competitors under this condition, standards and analytical procedures for this 
drug may not be available in the pharmacopoeias. It becomes necessary, therefore 
to develop newer analytical methods for such drugs.  
There are several valid reasons for developing new methods of analysis:  
 There may not be a suitable method for a particular analyte in the specific  
  sample matrix. 
 Existing method may be too erroneous or unreliable. 
 Existing method may not provide adequate sensitivity or analyte   
  selectivity in samples of interest. 
 Newer instrumentation and techniques may have evolved that          
provide opportunity for improved methods, including improved analyte  
identification or detection limits, greater accuracy or precision or better 
return on investment. 
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 There may be a need for an alternative method for legal or scientific 
reasons, to confirm analytical data obtained by existing methods. 
Goals for new or improved analytical method might include the following: 
 Qualitative identification of the specific analyte(s) of interest providing 
some structural information to confirm “general behavior” (e.g. retention 
time, colour change, pH etc). 
 Quantitative determination, at trace levels when necessary that is accurate, 
precise and reproducible in any laboratory setting when performed 
according to established procedures. 
 Ease of use, ability to be automated, high sample throughput and rapid 
sample turnaround time. 
 Decreased cost per analysis from using simple quality assurance and 
quality control procedures. 
 Sample preparations that minimize time, effort, materials and volume of 
sample consumed. 
  Steps Involved in Method Development: 
 Solubility Profile: 
Solubility information in different solvents is useful while selecting the 
diluents for standard solutions and extraction solvents for test solutions. 
 Analytical Profile: 
The spectral profile is useful in understanding the absorption characteristics, 
which helps in selection of detector and the wavelength for analysis. 
 Stability Profile: 
The information on the stability of the drug substance with respect to storage 
condition is useful as it helps in adopting suitable and adequate precautions 
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while handling drug substance and its solutions. 
 Selection and Optimization of Mobile Phase: 
The primary objective in selection and optimization of mobile phase is to 
achieve optimum separation of all the individual impurities and degradants 
from analyte (API) peak. The selection of mobile phase is done always in 
combination with selection of column (stationary phase). The following are 
the parameters, which shall be taken into consideration while selecting and 
optimizing the mobile phase. 
a) Buffer, if any and its strength 
b) pH of the buffer or pH of the mobile phase 
c) Mobile phase composition 
a) Buffer, if any and its Strength: 
Buffer and its strength play an important role in deciding the peak 
symmetries and separations. Various types of buffers can be employed for 
achieving the required separations. Some of the most commonly used buffers 
are: 
 Phosphate buffers - KH2PO4, K2HPO4, NaH2PO4, Na2HPO4, 
 H3PO4 etc., 
 Acetate buffers - Ammonium acetate, Sodium acetate etc., 
 Triethylamine/Diethylamine buffers 
 Buffers with various ion-pair reagents like Tetra butyl ammonium 
hydrogen sulphate 
The retention time also depend on the molar strength of the buffer. 
Ideally, the strength of the buffers shall be opted from 0.05 M to 0.20 M.  
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The selection of buffer and its strength is done always in combination 
with selection of organic phase composition in mobile phase. The strength of 
the buffer can be increased if necessary to achieve the required separations. 
But it is to be ensured that the higher buffer strengths shall not result in 
precipitations/turbidities either in mobile phase or in standard and test 
solutions while allowed to stand in bench top or in refrigerator. 
b) pH of the Buffer or pH of the Mobile Phase: 
pH plays an important role in achieving the chromatographic 
separations as it controls the elution properties by controlling the ionization 
characteristics. Depending on the pKa, drug molecules change retention.        
e.g. Acids show an increase in retention as the pH is reduced, while base show a 
decrease. 
c) Mobile Phase Composition: 
In reverse phase chromatography, the separation is mainly controlled by 
the hydrophobic interactions between drug molecules and the alkyl chains on 
the column packing material. Most widely used solvents in reverse phase 
chromatography are methanol and acetonitrile. 
 Selection of Column: 
Column plays the most important role in achieving the chromatographic 
separations. A column which separates all the impurities and degradants from 
API peak and which is rugged for variation in mobile phase shall be selected. 
Most chromatographic separations are achieved due to wide variety of 
columns available and due to flexibility to change and control each of the 
below parameters namely, 
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  Length and diameter of the column 
  Pore volume 
  Packing material 
  Surface area 
  Shape of the particles 
  End capping 
  Size of the particles 
  % of carbon loading 
 Selection of Flow Rate: 
Preferably the flow rate should NMT 2.5 ml/min. Check the ruggedness of the 
method by varying the flow rate by ±0.2 ml from the selected flow rate. Select 
the flow rate is based on the below parameters namely,  
 Retention time 
 Column back pressure 
 Separation of impurities 
 Peak symmetries 
 Selection of Injection Volume: 
Generally an injection volume of 10 to 20 µL is recommended for the 
estimation of API. However, if the extractions are found to be difficult, then 
the injection volume can be increased up to 50 µL. But it is to be ensured that 
at the selected injection volume, the column is not overloaded, resolution 
between individual impurities from API peak and the peak symmetry are not 
compromise.  
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 Selection of Column Temperature: 
Always it is preferable to optimize the chromatographic conditions with 
column temperature as ambient. However, if the peak symmetry could not be 
achieved by any combination of column and the mobile phase, then the 
column temperature above ambient can be adopted. The increase in column 
temperature generally will result in reduction in peak symmetry and peak 
retention. When found necessary, the column temperature between 30ºC and 
80ºC shall be adopted. If a column temperature of above 80ºC is found to be 
necessary, packing materials, which can withstand to that temperature shall be 
chosen. 
 Selection of Detector Wavelength: 
Selection of detector wavelength is a critical step in finalization of the 
analytical method. In most cases HPLC method development is carried out 
with UV detection using either a variable-wavelength or a photodiode array 
detector, which can provide an adequate response for most samples. 
 Establishment of System Suitability: 
System suitability parameter has to be selected based on the tailing factor, 
resolution, plate count and percentage RSD.  
1.7 Method Validation: 
11, 12 
 Method validation can be defined as “Establishing documented evidence, which 
provides a high degree of assurance that a specific activity will consistently 
produce a desired result or product meeting its predetermined specifications and 
quality characteristics”. 
 Method validation is an integral part of the method development. It is the process 
by which a method is tested by the developer or user for reliability, accuracy and 
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preciseness of its intended purpose and demonstrating that analytical procedures 
are suitable for their intended use that they support the identity, quality, purity 
and potency of the drug substances and drug products. Data thus generated 
become part of the methods validation package submitted to Center for Drug 
Evaluation and Research (CDER). Simply, method validation is the process of 
proving that an analytical method is acceptable for its intended purpose.  
 Methods should be reproducible when used by other analysts, on other equivalent 
equipment, on other days or locations and throughout the life of the drug product. 
Data that are generated for acceptance, release and stability or pharmacokinetic 
will only be trustworthy if the methods used to generate the data are reliable. The 
process of validation and method design also should be clear in the development 
cycle before important data are generated. Validation should be on going in the 
form of re-validation with method changes. 
 Though many types of HPLC techniques are available, the most commonly used 
method, the reversed-phase HPLC with UV detection, is selected to illustrate the 
parameters for validation. All the variables of the method should be considered, 
including sampling procedure, sample preparation, chromatographic separation, 
detection and data evaluation. For chromatographic methods used in analytical 
applications there is more consistency in validation practice with key analytical 
parameters including 
A) System Suitability 
B) Accuracy 
C) Precision 
D) Specificity 
E) Linearity 
CHAPTER - I                                                                                           Introduction                                                                                   
 
33 
F) Limit of Detection 
G) Limit of Quantitation  
H) Robustness 
I) Ruggedness 
A) System Suitability: 
 According to the USP, system suitability tests are an integral part of 
chromatographic methods. These tests are used to verify that the resolution and 
reproducibility of the system are adequate for the analysis to be performed. 
 System suitability tests are based on the concept that the equipment, electronics, 
analytical operations and samples constitute an integral system that can be 
evaluated as a whole. The purpose of the system suitability test is to ensure that the 
complete testing system (including instrument, reagents, columns and analysts) is 
suitable for the intended application. 
 System suitability is the checking of a system to ensure system performance before 
or during the analysis of unknowns. Parameters such as plate count, tailing factors, 
resolution and reproducibility (%RSD, retention time and area for six repetitions) 
are determined and compared against the specifications set for the method. 
 These parameters are measured during the analysis of system suitability "sample" 
that is a mixture of main components and expected by-products. Below Table 
(Table No. 4) shows the list of parameters to be measured and their recommended 
limits obtained from the analysis of the system suitability sample as per current 
FDA guidelines on "Validation of Chromatographic Methods". 
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Table No. 4. System Suitability Parameters and Recommendations 
S. No. Parameters Recommendations 
1 Capacity Factor (k’) The peak should be well-resolved 
from other peaks and the void 
volume, generally k’>2.0 
2 Repeatability RSD < 1% for N > 5 is desirable 
3 Relative Retention Not essential as long as the 
resolution is stated 
4 Resolution (Rs) Rs of > 2 between the peak of interest 
and the closest eluting potential 
interferent (impurity, excipient, 
degradation product, internal 
standard, etc. 
5 Tailing Factor (T) T of < 2 
6 Theoretical Plates (N) N > 2000 
 
B) Accuracy: 
 The accuracy of an analytical procedure expresses the closeness of agreement 
between the value which is accepted either as a conventional true value or an 
accepted reference value and the value found. 
Accuracy can usually be determined in one of three ways: 
 The procedure was applied to the known concentration of              
reference sample and the measured value to the true value was compared 
(defined by the organization, from which the sample received). 
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 The test results obtained were compared by the analytical procedure 
which was proved to be accurate with the results obtained from an 
existing alternate method that was known to be accurate. 
 Spiking concept, by spiking either analyte/impurities into sample matrix 
with one another. 
C) Precision: 
 The precision of an analytical procedure expresses the closeness of agreement 
(degree of scatter) between a series of measurements obtained from multiple 
sampling of the same homogeneous sample under the prescribed condition. ICH 
has defined; precision may be considered at three levels namely repeatability, 
intermediate precision and reproducibility.   
 Repeatability: 
Repeatability expresses the precision under the same operating conditions 
over a short interval of time. Repeatability is also termed intra- assay 
precision. 
 Intermediate Precision: 
Intermediate precision was previously known as part of ruggedness. The 
objective is to ensure that the method will provide the same results when 
similar samples are analyzed once the method development phase is over. 
Depending on time and resources, the method can be tested on multiple 
days, analysts, instruments, etc. 
 Reproducibility: 
Reproducibility expresses the precision between laboratories as in 
collaborative studies. Multiple laboratories are desirable but not always 
attainable because of the size of the firm. 
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D) Specificity: 
 The specificity of the method corresponds to the non-interaction of the placebo 
with that of the active particle. Typically these might include impurities, 
degradants, matrix, etc. 
E) Linearity: 
 A linear relationship should be evaluated across the range of the analytical 
procedure. Linearity should be evaluated by visual inspection of a plot of signals 
as a function of analyte concentration or content.  
 If there is a linear relationship, test results should be evaluated by appropriate 
statistical methods, for example, by calculation of a regression line by the method 
of least squares. The correlation coefficient, y-intercept, slope of the regression 
line and residual sum of squares should be submitted. A plot of the data should be 
included. In addition, an analysis of the deviation of the actual data points from 
the regression line may also be helpful for evaluating linearity. 
F) Limit of Detection (LOD): 
 The detection limit of an individual analytical procedure is the lowest amount of 
analyte in a sample which can be detected but not necessarily quantitated as an 
exact value. The detection limit is usually expressed as the concentration of the 
analyte (e.g. percentage or parts per million) in the sample and it can be 
calculated by using the following formula: 
LOD = 3 x Sa / b 
  Where, 
   Sa  =  Standard deviation of the intercept 
   b   =  Slope of the calibration curve 
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G) Limit of Quantitation (LOQ): 
 The quantitation limit of an individual analytical procedure is the lowest amount 
of the analyte in a sample that can be determined with acceptable precision and 
accuracy under the stated experimental conditions. The quantitation limit is 
usually expressed as the concentration of the analyte (e.g. percentage or parts per 
million) in the sample and it can be calculated by using the following formula: 
LOQ = 10 x Sa / b 
  Where, 
   Sa  =  Standard deviation of the intercept 
   b   =  Slope of the calibration curve 
H) Robustness: 
 The robustness of an analytical procedure is a measure of the method's capability 
to remain unaffected by small, but deliberate variations in method parameters 
such as flow rate, pH of the mobile phase, column temperature, percentage 
organic solvent strength and buffer concentration etc. It can be partly assured by 
good system suitability specifications.  
 If measurements are susceptible to variations in analytical conditions, the 
analytical conditions should be suitably controlled or a precautionary statement 
should be included in the procedure. One consequence of the evaluation of 
robustness should be that a series of system suitability parameters                    
(e.g. Resolution test) is established to ensure that the validity of the analytical 
procedure is maintained whenever used. 
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I) Ruggedness: 
 Method ruggedness is defined as the reproducibility of results when the method is 
performed under actual use conditions. This includes different analysts, 
laboratories, columns, instruments, source of reagents, chemicals, solvents etc. 
Method ruggedness may not be known when a method is first developed, but 
insight is obtained during subsequent use of that method. 
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CHAPTER - II 
 
DRUG PROFILE 
 
2.1 Codeine Phosphate: 
13 
  Structure:        
 
  CAS Number  : 76-57-3          
  Chemical Name  : 7,8-Didehydro-4,5 alpha-epoxy-3-methoxy-17-   
                                                       methyl morphinan-6 alpha-ol phosphate (1:1)         
                                                       (Salt) hemihydrates 
  Molecular Formula  : C18H21NO3 H3PO4 ½H2O        
  Molecular Weight : 406.4          
  Physical Properties : White crystalline powder, Odourless and     
Bitter taste     
  Solubility : Soluble in water 
  pKa :        8.21 
  Category : Antitussive and Analgesic 
  Dose :         30 to 60 mg every 4 hours when necessary, to      
                                                       maximum of 200 mg daily    
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Mechanism of Action: 
 Codeine phosphate is an opioid analgesic which binds with stereo specific 
receptors at many sites within the CNS to alter processes affecting both the 
perception of pain and the emotional response to pain. There are multiple sub 
types of opioid receptors, each mediating various therapeutic and/or side effects 
of drugs. Codeine has about one-sixth the analgesic activity of morphine. 
Pharmacokinetics: 
 Codeine is readily absorbed from the gastro-intestinal tract and metabolized by 
O-and N-demethylation in the liver to morphine and nor codeine which with 
codeine are excreted almost entirely by the kidney, mainly as conjugates with 
glucuronic acid. 
 Most of the excretion products appear in the urine within 6 hours and 40 to 60 
percent of the codeine is excreted free or conjugated, approximately 5 to 15 
percent as free and conjugated morphine and about 10 to 20 percent as free and 
conjugated norcodeine. 
Dose and Method of Administration: 
 Adults: Codeine phosphate may be given orally in doses of 15 mg-60 mg every 
4-6 hours as needed. It these doses fail to relive pain, larger doses rarely succeed 
and may give rise to restlessness and excitement. The maximum recommended 
daily dose is 300 mg. 
 Paediatric: The usual paediatric dose for infants and children is 0.5 mg per kg of 
body weight or 15 mg per square metre of body surface, every 4 to 6 hours as 
needed. The maximum recommended dose is 240 mg in 24 hours. The duration 
of treatment should not normally exceed 3 days. 
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Side Effects: 
Common side effects of Codeine phosphate include: 
  Drowsiness, Rash 
  Light headedness, Dependence 
  Dizziness, Seizures 
  Sedation, Confusion 
  Shortness of breath 
  Nausea, Near-fainting 
  Vomiting 
  Stomach pain 
  Sweating 
  Constipation 
  Itching 
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2.2 Triprolidine Hydrochloride: 
14 
  Structure:       
 
 
  CAS Number  : 6138-79-0 
  Chemical Name  : (E)-2-(3-pyrolidine-1-yl-1-(p-tolyl) prop-1-enyl 
                                                       pyridine hydrochloride monohydrate                                 
  Molecular Formula  : C19H22N2 HCl H2O 
  Molecular Weight  :     332.9 
  Physical Properties  :     White crystalline powder, almost Odourless 
  Category   :     Histamine H1-receptor antagonist 
  Dose    :      10-20 mg daily in divided doses        
Mechanism of Action: 
 Triprolidine hydrochloride exerts its action by acting as an H1 receptor 
antagonist. It antagonizes most of the pharmacological actions of histamine and 
reduces allergic symptoms. It also has anticholinergic properties and reduces 
secretions. 
Pharmacokinetics: 
 Triprolidine hydrochloride is well absorbed orally. It is widely distributed in the 
body. It is mainly metabolized in the body by carboxylation and it is excreted 
through urine.   
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Side Effects: 
Common side effects of Triprolidine hydrochloride include: 
  Drowsiness 
  Dizziness, Headache 
  Nausea, Vomiting 
  Loss of appetite 
  Constipation 
  Stomach upset 
  Blurred vision 
  Dry mouth / Throat 
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CHAPTER - III 
 
LITERATURE REVIEW 
 
 Manassra et al., 
15
 proposed Simultaneous HPLC analysis of Pseudophedrine 
hydrochloride, Codeine phosphate and Triprolidine hydrochloride in liquid 
dosage forms. C18 column (250 x 4.0 mm) is used as the stationary phase with a 
mixture of Methanol:Acetate buffer:Acetonitrile (85:5:10, v/v) as the mobile 
phase. The factors affecting column separations of the analytes were studied. The 
calibration graphs exhibited a linear concentration range of 0.06-1.0 mg/ml for 
Pseudoephedrine hydrochloride, 0.02-1.0 mg/ml for Codeine phosphate and 
0.0025-1.0 mg/ml for Triprolidine hydrochloride for a sample size of 5 µl with 
correlation coefficients of better then 0.999 for all active ingredients studied. The 
results demonstrate that this method is reliable, reproducible and suitable for 
routine use. 
 Capella-Peiro et al., 
16
 optimized Capillary Zone Electrophoresis method to 
quantitatively determine Codeine and Paracetamol via Central composite factorial 
design. Optimum separation conditions were achieved using Phosphate buffer 20 
mm (pH 6.8) and voltage (15 kv). The optimized Procedure easily determination 
Codeine and Paracetamol with separation in less then 3 min. Calibration curves 
(R>0.999) were prepared, with LODs of 13.5 and 340 mg/ml for Codeine and 
Paracetamol respectively and a good RSD % (<3%). This method was applied to 
determine Codeine and Paracetamol in pharmaceutical formulations; recoveries 
coincided with stated contents. 
 Gomez et al., 
17
 described a simple, accurate and rapid method for the separation 
and Simultaneous determination of Codeine, Diphenhydramine, Ephedrine and 
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Noscapine present in cough-cold syrup formulations by Capillary Zone 
Electrophoresis. Separations were carried out in less then 10 min with a    20 mm 
Sodium tetra borate buffer, pH 8.5, the carrier electrolyte gave baseline 
separation with good resolution, great reproducibility and accuracy. 
 Kartal et al., 
18
 proposed LC method for the analysis of Paracetamol, Caffeine 
and Codeine phosphate in pharmaceutical preparation. Paracetamol, Caffeine and 
Codeine phosphate were separated using a µ bond pack C8 column by isocratic 
elution with flow rate 1.0 ml/min. the mobile phase composition was 
420/20/30/30 (v/v/v/v) 0.01m KH2PO4, Methanol, Acetonitrile, Isopropyl alcohol 
and Spectrophotometric detection was carried out at 215 nm. The linear range of 
detection for Paracetamol, Caffeine and Codeine phosphate was between 0.400 
and 1500 µg/ml; 0.075 and 90 µg/ml; 0.300 and 30 µg/ml respectively. The 
method has been shown to be linear, reproducible, specific, sensitive and rugged. 
 Hood et al.,
19
 developed a simple, accurate and precise RP-HPLC method for 
rapid and Simultaneous analysis of Codeine phosphate, Ephedrine HCl and 
Chlorpheniramine maleate in a cough-cold syrup formulation. Separations were 
carried out on a zorbax XDB C8 column (150 mm ID), 5 µm particle size.          
A gradient elution system was developed using varying percentages of two 
mobile phases: Methanol:Glacial acetic acid:Triethylamine (980:15:5 v/v) and 
Water:Glacial acetic acid:Triethylamine (980:15:5 v/v) with run time in less than 
7 min with a flow rate of 1.5 ml/min and detected at a wavelength of 254 nm. The 
method was validated and met all analysis requirements of quality assurance and 
quality control recommended by FDA of the USA. 
 Ragonese et al., 
20
 described full and fractionated experimental designs for 
Robustness Testing in the High Performance Liquid Chromatographic Analysis. 
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A full factorial design relies on fewer assumptions and hence could be used to 
evaluate the effectiveness of the saturated design. Both designs were used to test 
a gradient HPLC method for the assay of Codeine phosphate, Pseudoephedrine 
hydrochloride and Chlorpheniramine maleate. Six HPLC conditions, including 
Wavelength, mobile phase pH and ion pairing reagent concentration were tested 
using the saturated design. One interaction effect was indicated as a confounding 
effect by the saturated design and this was confirmed by the calculating of the 
robust under the variety of HPLC conditions tested. 
 Lau et al., 
21
 proposed HPLC method using indirect conductometric detection for 
the Simultaneous determination of eight active ingredients in cough-cold syrups. 
It involves the use of an ultra here 5 µm spherical 80 A
o
 pore Cyano analytical 
column (250 x 4.6 mm) as the stationary phase with a mixture of Water, 
Acetonitrile and Ethanol (38:60:2) containing 1mm Perchloric acid as the mobile 
phase. The active ingredients included Bromhexine hydrochloride, 
Chlopheniramine maleate, Codeine phosphate, Dextromethorphan hydrobromide, 
Diphenhydramine hydrochloride, Ephedrine hydrochloride, Papaverine 
hydrochloride and Phenylephrine hydrochloride. 
 Weingarten et al., 
22
 developed a rapid, reliable and rugged assay for 
determining Codeine in human plasma using Reverse Phase HPLC with 
Fluorescence detection. This analytical method utilized an ion-exchange/ mixed-
mode solid phase extraction procedure. The chromatographic separation was 
achieved using a 150 x 4.6 mm ID, 3 µm Reversed Phase C8 column at ambient 
temperature. Fluorescence detection (excitation at 214 nm and emission above 
345 nm) for Codeine and Nalorphine allowed for a detectable limit of 5 µg/ml. 
The results showed that the method was linear from 10 to 300 ng/ml. The method 
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had good reproducibility, precision, accuracy and recoveries of 91 and 90% for 
Codeine and Nalorphine respectively. This method has been applied to study the 
pharmacokinetics of Codeine in normal human subjects. 
 Santoni et al., 
23
 developed a Reverse Phase HPLC method for the Simultaneous 
determination of Aspirin, Codeine phosphate and Propylphenazone in analgesic 
tablet formulation. The proposed method is also suitable for the determination of 
small quantities of Salicylic acid. The elution was isocratic using two C8 column 
and Methanol:Water (45:55) as mobile phase with 1.4% Acetic acid and 5 mm 
Tetramethyl ammonium bromide. 
 Chen et al., 
24
 developed a novel HPLC method for the Simultaneous 
determination of Codeine, Norcodeine and Morphine in plasma and urine. The 
compounds were separated on a cyano column (15 cm x 4.6 mm, 5 µm particle 
size) using a mobile phase of Acetonitrile-Triethylamine-Distilled water 
(4:0.1:95.9, v/v) pH 3.1 and then determined by Fluorescence detection. 
Calibration curve in the range 5-200 ng/ml for plasma and 0.1-10 µg/ml for urine 
were linear and passed through the origin. The imprecision and inaccuracy of the 
assay were less then 10% and the limits of detection were 2 µg/ml for all three 
compounds in human plasma. 
 Ginman et al., 
25
 described a procedure for the Simultaneous determination of 
Codeine and Ibuprofen in human plasma by HPLC with Fluorescence detector. 
The Codeine was first extracted from alkalinized plasma with Hexane: 
Dichloromethane (2:1, v/v) and then washed with sodium hydroxide solution. 
The Ibuprofen was then extracted with hexane from the plasma acidified with 
sulphuric acid. The organic layers were collected, evaporated to dryness and the 
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reconstituted residue was subjected to HPLC. The detection limit for codeine was 
8 µg and for Ibuprofen 1mg. 
 Davidson et al., 
26
 described Spectrophotometric procedures for the assay of 
Triprolidine hydrochloride, Pseudoephedrine hydrochloride and 
Dextromethorphan hydrobromide in Actifed formulation. Triprolidine is assayed 
by the measurement of the difference absorbance at 301 nm between equimolar 
solutions of the sample extract in 0.1 M sulphuric acid and 0.1 M sodium 
hydroxide in ethanol (20% v/v). Dextromethorphan and Pseudoephedrine are 
assayed by measurement of the amplitudes in the second and fourth derivative 
spectra of the difference absorption spectrum of the sample solution. The 
measured values are proportional to the concentration of the drugs. The accuracy, 
precision and selectivity of the procedures are discussed. Applications of the 
assay are described for Actifed syrup and Actifed tablets. 
 El-Gindy et al., 
27
 developed HPLC method for the analysis of Paracetamol, 
Pseudoephedrine, Triprolidine, Methylparaben, Propylparaben, Sodium benzoate 
and their related substances including p-Aminophenol, Triprolidine Z-isomer,    
4-hydroxy benzoic acid, and 4-chloroacetanilide in pharmaceutical syrup using 
C18 column at 25ºC with UV detection at 214 nm. A linear gradient elution was 
employed starting with 100% mobile phase A and 0% mobile phase B for 5 min 
to reach 40% mobile phase B at 16 min then 0% mobile phase A and 100% 
mobile phase B at 28 min. The total run time is 30 min using solution of 28 mM  
Sodium dehydrogenate phosphate containing 2.6 mM Hexane sulphonic acid 
sodium salt and adjusted to apparent pH 3.0 with Phosphoric acid-Acetonitrile in 
ratios of (90:10 v/v) and (60:40 v/v) as mobile phase A and mobile phase B 
respectively. All the mentioned compounds have been successfully separated and 
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quantified using the developed method. The developed method was linear with 
(r=0.9999) for all compounds. The proposed method was completely validated. 
 Sriphong et al., 
28
 developed Spectrophotometric method for Simultaneous 
Quantification of Triprolidine hydrochloride and Pseudoephedrine hydrochloride 
using second derivative method (zero-crossing technique). The second derivative 
amplitudes of Pseudoephedrine hydrochloride and Triprolidine hydrochloride 
were measured at 271 and 321 nm, respectively. The calibration curves were 
linear in the range of 200 to 1000 µg/ml for Pseudoephedrine hydrochloride and 
10 to 50 µg/ml for Triprolidine hydrochloride. The method was validated for 
specificity, accuracy, precision, limit of detection and limit of quantitation. The 
proposed method was applied to the assaying and dissolution of Pseudoephedrine 
hydrochloride and Triprolidine hydrochloride in commercial tablets without any 
chemical separation. The results were compared with those obtained by the 
official USP method and statistical tests showed that there is no significant 
between the methods at 95% confidence level. The proposed method is simple, 
rapid and suitable for the routine quality control application. 
 Caglar et al., 
29
 developed a simple Reverse Phase HPLC method for 
Simultaneous determination of Pseudoephedrine hydrochloride, Pheniramine 
maleate, Acetaminophen, Guaifenisin, Pyrilamine maleate, Chlorpheniramine 
maleate, Triprolidine hydrochloride, Dextromethorphan hydrobromide and 
Diphenhydramine hydrochloride in cough and cold pharmaceuticals. The 
separation of these compounds was achieved within 37.9 min on a nucleolus 
gravity C18 column (250 x 4.0 mm, 5 µm). The chromatographic separation of 
these compounds performed in a single run by using isocratic mobile phase 
consisting of Methanol:Buffer mixture (38:62, v/v) at roomtemperature, with 
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flow rate of 0.75 ml/min. An Ultraviolet absorption at 210 nm was monitored. 
2,4,6-Trimethoxy benzaldehyde was used as an internal standard. The selectivity, 
linearity of calibration, accuracy, interday and intraday precision and forced 
degradation studies were examined as parts of the method validation. The 
concentration-response relationship was linear over a concentration range of   
0.2-250 µg/ml for Acetaminophen, 0.5-250 µg/ml for Pseudoephedrine 
hydrochloride and Pheniramine maleate, 1-250 µg/ml for Guaifenisin,             
2.5-250 µg/ml for Chlorpheniramine maleate and Triprolidine hydrochloride,     
5-250 µg/ml for Pyrilamine maleate and Diphenhydramine hydrochloride,        
10-20 µg/ml for dextromethorphan hydrobromide with correlation coefficients 
better then 0.9993. The relative standard deviations of the intraday and intraday 
were all less than 4%. 
 De Orsi et al., 
30
 developed a simple, rapid and specific HPLC method for the 
Simultaneous determination of Triprolidine, Pseudoephedrine, Paracetamol and 
Dextromethorphen, in combination and in different pharmaceutical dosage forms 
using a Reverse Phase C18 column, gradient elution and UV detection at 254 and 
280 nm. No preliminary extraction procedure is required for liquid formulation 
and a very simple extraction procedure is required for tablets and creams. The 
recovery of the drugs ranged from 96.0 to 98.7%. The assay results obtained for 
eight commercially available formulations were in agreement with the amounts 
declared. The linearity and precision of the method have been assessed. 
 Mallu et al., 
31
 developed for the determination of ten active Ingredients 
(Codeine phosphate, Paracetamol, Chloropheniramine maleate, Theophylline, 
Pseudoepidrine hydrochloride, Ambroxol, Salbutamol, Guaiphenesin, 
Dextromethorphan and Diphenhydramine hydrochloride) in all pharmaceutical 
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dosage forms, along with preservative (Sodium benzoate) and validated the 
method as per ICH and FDA guidelines. The separation was achieved on a        
X-terra C18 column (15 cm x 4.6 mm, 3.5 µm in the simple gradient mode using 
Sol-A; Buffer and Sol-B: Acetonitrile (0.5 min, Sol-A: 97-97; 5-10 min, Sol-A: 
97-92;  10-15 min, Sol-A: 92-68; 15-23 min, Sol-A: 68-68; 23-25 min, Sol-A:  
68-97 and 25-30 min, Sol-A: 97-97) with 0.8 ml per min flow rate. Column oven 
temperature maintained at 40 ºC and performed the analysis with 220 nm. 
Quantification was achieved with 40 µg per ml for all ingredients with             
100 ± 3.0% recoveries. The method was validated by determining its sensitivity, 
linearity, accuracy and precision. The proposed method is single, shorter runtime, 
accurate and reproducible. This method can be applied for routine analysis of all 
ten active ingredients quantification in all pharmaceutical dosage forms. 
 Paidipala et al., 
32
 described a simple, selective, sensitive and precise 
Simultaneous HPLC analysis of tablets containing Dextromethorphan           
hydrobromide, Phenylephrine hydrochloride and Triprolidine hydrochloride. 
Good chromatographic separation was achieved using a kromasil C18 (250 x 4.6 
mm, 5 µm) and mobile phase consisting of Methanol:Acetonitrile:0.1M 
Potassium dihydrogen orthophosphate buffer (75:15:10), adjusted to pH 6.8 with 
sodium hydroxide, at flow rate 1 ml/min. the PDA detector was used. The 
retention time of Dextromethorphan hydrobromide, Phenylephrine hydrochloride 
and Triprolidine hydrochloride were measured at 2.547, 3.783 and 6.017 min, 
respectively. The linear ranges for Dextromethorphan hydrobromide, 
Phenylephrine and Triprolidine hydrochloride were 48-112, 24-56 and 16-14 
µg/ml, respectively. The recoveries of Dextromethorphen hydrobromide and 
Phenylephrine hydrochloride and Triprolidine hydrochloride in pharmaceutical 
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preparation were all greater than 98% and their relative standard deviations were 
NMT 2.0%. The limit of detection was 3.71, 1.90 and 0.52 µg /ml. The proposed 
method can be effectively applied for the Simultaneous estimation of three drugs 
in bulk and in combined dosage form. 
 Hinge et al., 
33
 developed First order derivative Spectrophotometric and HPLC 
methods for the determination of Triprolidine and Pseudoephedrine 
hydrochloride in tablet dosage form. In UV Spectrophotometric method, 
estimation of Triprolidine and Pseudoephedrine hydrochloride was carried out at 
the wavelength selected 246.20 nm and 263.50 nm for first order derivative 
method. Calibration curves were linear in the range of 2-10 µg/ml for 
Triprolidine and 48-240 µg/ml for Pseudoephedrine hydrochloride in derivative 
method. Correlation coefficient found to be close to 0.9950 for both the drugs. 
Accuracy for both the drugs was in the range of 99-101.5%. A simple liquid 
chromatography assay has been developed for the determination of Triprolidine 
and Pseudoephedrine hydrochloride. A column of C18 (250 x 4.6 mm, 5 µm) was     
used with a mobile phase consisting of Methanol:Water (80:20 v/v) at a flow rate 
of 1.0 ml/min and pH also adjusted to 3.0 with Orthophosphoric acid. 
Quantitation was achieved with UV detection at 246.20 nm based on the peak 
height ratios. Beer’s law was obeyed in a concentration range of 5-25 µg/ml for 
Triprolidine and 120-600 µg/ml for Pseudoephedrine hydrochloride. 
 Abu Reid et al., 
34
 developed a Spectrophotometric method for the Simultaneous 
determination of Pseudoephedrine HCl (PSE) and Triprolidine HCl (TRI) in bulk 
and dosage forms. The method involved the determination of Pseudoephedrine in 
the presence of Triprolidine using two wavelengths (257 nm & 290 nm). Beer’s 
law was obeyed in the concentration (152-760 µg/ml) and (6.4-32 µg/ml) with 
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good linearity (0.9996 and 0.9996) for Pseudoephedrine and Triprolidine 
respectively. The accuracy and the precision of the developed method were very 
good (RSD ˂ 2%). The validity of the proposed method was confirmed through 
the statistical comparison of the obtained data with those of the official USP 
method. 
 Arif Aziz et al., 
35
 developed for the Simultaneous HPLC determination of 
Paracetamol with a various range of API’S (Active Pharmaceutical Ingredients) 
like Caffeine, Phenobarbital, Acetyl salicylic acid, Phenobarbital, Phenylephrine 
hydrochloride and Diphenhydramine hydrochloride, Salicylamide, Guaifenesin 
hydrochloride, Chlorpheniramine maleate, and Promethazine hydrochloride and 
excipients like Sodium benzoate, Propyl paraben, Para aminophenol,                  
4-Chloracetanilide and Methyl paraben in different dosage forms. Six methods 
are reviewed and discussed for the Simultaneous determination of Paracetamol. 
First method was related to HPLC chromatographic assay of Caffeine, Acetyl 
salicylic acid, Paracetamol, Phenobarbital in tablet formulation is performed 
using RP-HPLC technique with column C18, mobile phase Acetonitrile and 
Water with adjusted pH 2.5 having flow rate 2.0 ml/min at 207 nm. Second 
method was the assay of Paracetamol and Acelofenac, a RP-HPLC method at  
265 nm using Hichrome C18, mobile phase Acetonitrile and Phosphate buffer 
having 0.8 ml/min. Third method was the estimation of Triprolidine, 
Pseudoephedrine, Dextrometherphan and Paracetamol where chromatography is 
carried put through C18 RP-HPLC technique first at 254 nm then 280 nm. Fourth 
method was for the Ibuprofen and Paracetamol having system parameter 
comprises of C18 column with eluent pH 7 (Acetonitrile and Phosphate buffer) 
and elution at 8.0 ml/min. Peaks were detected through UV detector 260 nm. 
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Fifth method was for Paracetamol and Camylofin dihydrochloride with C18 
column at 220 nm using Methyl paraben as Internal standard. Last method but no 
least was done through gradient system at 215 nm with 40 mins run time. These 
six assays procedures can be used in any pharmaceutical lab the analysis of 
Paracetamol Combination in tablet, syrup, suspension and bulk. 
 Ma et al., 
36
 developed a new Chemiluminescence method with flow Injection 
analysis for the determination of Triprolidine hydrochloride. It was based upon 
the significant enhancing effect of Triprolidine Hydrochloride on the 
Chemiluminescence reaction of N-bromo succinimide with Luminal in presence 
of gold nanoparticles as a catalyst. Under the optimum conditions, the relative 
Chemiluminescence intensity was linearly related to the concentration of 
Triprolidine hydrochloride in the range of 1.0 -750.0 µg/ml. The detection limit 
(3Sb/S) was 0.2 µg/L and the relative standard deviation was 1.2% for 0.1 mg/L 
Triprolidine hydrochloride solution (n=11). The method was applied to the 
determination of Triprolidine hydrochloride in capsules and the study of 
interactions of Triprolidine hydrochloride with serum albumins.  
 Vijai Anand et al.,
 37
 developed a simple, specific, accurate and stability 
indicating RP-HPLC method for the Simultaneous determination of Codeine 
phosphate, Chlorpheniramine maleate and Sodium benzoate in cough syrup 
formulation using Zodiac C18, 3.5 µ, 150 x 4.6 mm column eluted with      
Solvent-A: Phosphate buffer (pH-2.3), Solvent-B: Acetonitrile by gradient elution 
pattern at a flow rate of 1.5 ml/min and a detection wavelength of 254 nm with 
injection volume of 50 µl at ambient (30ºC) temperature afforded the best 
separation of these analytes. The retention time of Codeine phosphate, 
Chlorpheniramine maleate and Sodium benzoate were found to be 7.18 min, 9.46 
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min and 10.86 min respectively. The system precision of this method was 
evaluated by calculating the %RSD of the peak areas of six replicate injections of 
the standard solution, which were found to be 0.41%, 0.35% and 0.37%. 
Accuracy studies were performed where the % recovery of three drugs was found 
to be 98.7%, 98.5% and 99.1% respectively. Linearity was established for 
Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate in the range 
of 12.5-75 µg/ml, 5-30 µg/ml and 12.5-75 µg/ml respectively. Specificity of the 
current methods was demonstrated by good separation of the three analytes a 
small change in the following chromatographic parameters: Flow rate: 1.4 and 
1.6 ml/min instead of 1.5 ml/min and pH of the buffer preparation in mobile 
phase: 2.2 and 2.4 instead of 2.3. The %RSD’s were found to be within the limits. 
Ruggedness was demonstrated by analyzing three samples (assay) of syrup 
formulation by two analysts in the same laboratory on to different days. The       
%RSD values for the 12 samples are calculated to be guidelines and shown to be 
accurate, precise and specific. This method is agreeable to the routine analysis 
and can be successfully employed for simultaneous quantitative analysis of 
Codeine phosphate, Chlorpheniramine malealte and Sodium benzoate 
respectively in bulk drugs and formulations. 
 Kazemi et al., 
38
 studied a sensitive method for the determination of Codeine 
phosphate in water samples using Dispersive Liquid-Liquid Microextraction 
coupled with UV spectrophotometry. Parameters that affect on the extraction 
efficiency, such as kind and volume of the extraction and disperser solvent, 
extraction time, salt addition were investigated and optimized. Under the optimal 
conditions, the linearity of the method was obtained in the range 0.005-10 µg/ml 
with coefficient of (r²) 0.9996. 
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 Geetha Lakshmi et al., 
39
 developed and validated an accurate, sensitive, precise 
and robust RP-HPLC method for Simultaneous estimation of Codeine phosphate, 
Chlorpheniramine maleate and its Preservative in syrup formulation. 
Chromatographic separation was conducted on zodiac C18 (150 x 4.6 mm,       
3.5 µm) column at ambient temperature using phosphate buffer (pH adjusted to 
2.3 with Ortho phosphoric acid), Acetonitrile in gradient mode at a flow rate of 
1.5 ml/min, while UV detection was performed at 254 nm. The retention time for 
Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate was found 
to be 7.169, 9.480 and 10.860 respectively. The method was found to be linear in 
the 12.5-75 µg/ml for Codeine phosphate, 5-30 µg/ml for Chlorpheniramine 
maleate and Sodium benzoate was found to be 98.7%, 98.5% and 99.1%, 
respectively. The developed method was validated in terms of accuracy, 
specificity, robustness, Precision and ruggedness. This method can be 
successfully used for the estimation of Codeine phosphate, Chlorpheniramine 
maleate and Sodium benzoate in bulk and syrup formulations. 
 Nazir et al., 
40
 developed and validated for a Reverse Phase HPLC method for 
Simultaneous determination of active ingredients like Paracetamol, Caffeine and 
Codeine phosphate in pharmaceutical formulation. A mobile phase of 
Water:Acetonitrile:Methanol (60:15:25 v/v/v) was run on a C18 column, at the 
flow rate of 1 ml/min and UV detection was performed at 240 nm. The retention 
times were 9.13, 7.78 and 6.42 for Caffeine, Paracetamol and Codeine phosphate 
respectively. The RSD qualities are less then 2%, which showed that developed 
method was accurate and suitable for expected utilization. The method was 
validated with respect to the precision, accuracy and specificity of the 
Paracetamol, Caffeine and Codeine phosphate in pharmaceutical formulation.             
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CHAPTER - IV 
 
AIMS AND OBJECTIVES 
      
 Codeine phosphate and Triprolideine hydrochloride combination is an 
Antitussive, Analgesic and Antagonist of the H1 histamine receptor. Codeine 
phosphate is often sold in combination with other ingredients such as in many 
cough analgesic medications.  
 Codeine phosphate is an opioid analgesic which binds with stereo specific 
receptor at many sites within the CNS to alter processes affecting both the 
perception of pain and the emotional response. Triprolidine hydrochloride binds 
to the histamine H1 receptor. 
 Codeine phosphate and Triprolidine hydrochloride are official in the Indian 
Pharmacopoeia from the literature survey. It was found that there were only few 
RP-HPLC methods reported for the Simultaneous determination of content of 
Codeine phosphate and Triprolidine hydrochloride in cough syrup formulation. 
 Hence, the main aims and objectives of the present work is to develop new      
RP-HPLC method for the Simultaneous determination of content of Codeine 
phosphate and Triprolidine hydrochloride in cough syrup formulation and to 
validate for the developed method by validated parameters (as per ICH 
guidelines) like System suitability, Accuracy, Precision, Specificity, Linearity, 
Robustness and Ruggedness. 
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CHAPTER - V 
 
INSTRUMENTS AND CHEMICALS 
 
Table No. 5. List of Instruments Used 
 
S. No. Name Model 
1 Weighing balance BT 224 S / Sartorius 
2 pH
 
meter pH 211 / Hanna  
3 Sonicator Ultrasonic Bath / PCI 
4 HPLC – UV / PDA 1220 infinity / Agilent 
5 Column Inersustain / Inertsil 
 
Table No. 6. List of Chemicals Used 
 
 
 
 
Table No. 7. List of Active Pharmaceutical Ingredients Used 
 
S. No. Name Specification 
1 Codeine phosphate Reference Standard 
2 Triprolidine hydrochloride Reference Standard 
 
S. No. Name Grade / Supplier 
1 Methanol HPLC /  Moly Chemicals 
2 Potassium dihydrogen 
orthophosphate 
HPLC /  Rankem Chemicals 
3 Orthophosphoric acid HPLC /  Rankem Chemicals 
4 Milli-Q water HPLC /  In House Production 
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CHAPTER - VI 
 
METHOD DEVELOPMENT 
                
 The method development stage, decision regarding choice of column, mobile 
phase, detectors and method of quantitation must be addressed.  
 In this way, development considers all the parameters pertaining to any methods. 
So here the trials mentioned describes how the optimization was done. 
 Selection of Stationary Phase: 
Proper selection of the stationary phase depends up on the nature of the 
sample and chemical profile. The drugs selected for the present study were 
polar compounds and could be separated either by Normal phase 
chromatography or Reverse phase chromatography. From literature survey, it 
was found that different C18 column could be appropriately used for the 
quantitation of Codeine phosphate and Triprolidine hydrochloride. 
 Selection of Mobile Phase: 
The mobile phase was selected and chromatograms were recorded, trials were 
done on different mobile phase.   
 Selection of Wavelength: 
The sensitivity of the HPLC method depends upon the selection of detection 
wavelength. An ideal wavelength is one that gives good response for related 
substance and the drugs to be detected. The wavelength for measurement was 
selected as 280 nm from the absorption spectrum. 
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6.1 Reagent Preparation and Assay: 
 Preparation of Buffer Solution: 
8.1654 gm of potassium dihydrogen orthophosphate was weighed and 
dissolved in 1000 ml of water and pH was adjusted to 3.0 with 
orthophosphoric acid.   
 Solution A - Buffer  :  Methanol (50:50) 
 Solution B - Methanol :  Buffer (50:50) 
 Mobile Phase  - Solution A :  Solution B (55:45) 
 Diluents  - Mobile phase  
 Standard Preparation: 
Weigh accurately about 10 mg of Codeine phosphate and 12.5 mg 
Triprolidine hydrochloride working standards and transfer into a 50 ml 
volumetric flask, add  70 ml of diluents and sonicate to dissolve it completely 
and make the volume up to the mark with the same solvent. Further pipette    
5 ml of the above stock solution into 25 ml volumetric flask and dilute up to 
the mark with diluents, mix well and filter through 0.45 µm filter. Inject 20 µl 
of the standard solution into a chromatographic system and measure the area 
for the Codeine phosphate and Triprolideine hydrochloride peaks. 
 Assay: 
Accurately pipette out 5 ml of the sample into a 100 ml volumetric flask and 
70 ml of diluents was added and mixed well and made up to the mark with 
diluents. Mix well and filter through 0.45 µm filter. Measure the area for the 
Codeine phosphate and Triprolideine hydrochloride peaks and calculate the 
percentage assay by using formula. 
 
CHAPTER - VI                                                                           Method Development                                                       
 
61 
 Calculation: 
                                AT        WS      DT        P          Wt/ml 
                            ------- × -------× -------× -------×----------------×100 
                                AS         DS      WT     100     Label claim 
Where, 
AT = Peak area of sample solution 
AS = Peak area of standard solution 
WS = Weight of working standard taken in mg 
WT = Weight of sample taken in mg 
DS = Dilution of standard solution 
DT = Dilution of sample solution  
 P = Percentage purity of working standard 
6.2 Trials: 
 Trial:1 
 Buffer Preparation: 
8.272 gm (0.08 M) potassium dihydrogen orthophosphate was weighed and 
transfered to 1000 ml standard flask and volume was made up with water and 
then pH was adjusted to 3.0 using orthophosphoric acid. 
 Solution A  - Buffer  :    Methanol (50:50) 
 Solution B  - Methanol :    Buffer (50:50) 
 Mobile Phase  - Solution A :    Solution B (55:45) 
 Chromatographic Conditions: 
 Column   :  Inersustain C18  
      (250 x 4.6 mm, 5µ) 
 Detector Wavelength :  210 nm 
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 Column Temperature :  30 ºC 
 Injection Volume  :  20 µl 
 Flow Rate   :  1.0 ml/min 
 Run Time   :  15 min 
 Observation: 
Peak shape was not good for Codeine phosphate and Triprolidine 
hydrochloride. The chromatogram was shown in Figure No. 11. 
Figure No. 11. Chromatogram of Trial:1 
(Codeine phosphate and Triprolidine hydrochloride) 
 
 
 Trial:2 
 Buffer Preparation: 
8.0742 gm (0.04 M) potassium dihydrogen orthophosphate was weighed and 
transfered to 1000 ml standard flask and volume was made up with water and 
then pH was adjusted to 3.0 using orthophosphoric acid. 
 Solution A  - Buffer  :    Methanol (50:50) 
 Solution B  - Methanol :    Buffer (50:50) 
 Mobile Phase  - Solution A :    Solution B (55:45) 
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 Chromatographic Conditions: 
 Column   :  Inersustain C18  
      (250 x 4.6 mm, 5µ) 
 Detector Wavelength :  240 nm 
 Column Temperature :  30 ºC 
 Injection Volume  :  20 µl 
 Flow Rate   :  1.0 ml/min 
 Run Time   :  15 min 
 Observation: 
Peak shape was not good for Codeine phosphate and Triprolidine 
hydrochloride and also theoretical plate was less. The chromatogram was 
shown in Figure No. 12. 
Figure No. 12. Chromatogram of Trial:2 
(Codeine phosphate and Triprolidine hydrochloride) 
 
 
 Trial:3 (Optimized Method) 
 Buffer Preparation: 
8.1654 gm (0.06 M) potassium dihydrogen orthophosphate was weighed and 
transfered to 1000 ml standard flask and volume was made up with water and 
then pH was adjusted to 3.0 using orthophosphoric acid. 
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 Solution A  - Buffer  :    Methanol (50:50) 
 Solution B  - Methanol :    Buffer (50:50) 
 Mobile Phase  - Solution A :    Solution B (55:45) 
 Chromatographic Conditions: 
 Column   :  Inersustain C18  
      (250 x 4.6 mm, 5µ) 
 Detector Wavelength :  280 nm 
 Column Temperature :  30 ºC 
 Injection Volume  :  20 µl 
 Flow Rate   :  1.0 ml/min 
 Run Time   :  15 min 
 Observation: 
Resolution was satisfactory for Codeine phosphate and Triprolidine 
hydrochloride and also peak shape was good. The chromatogram was shown 
in Figure No. 13 and the results obtained were tabulated as shown in       
Table No. 8. 
Figure No. 13. Chromatogram of Trial:3 - Optimized Method 
(Codeine phosphate and Triprolidine hydrochloride) 
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Table No. 8. Results of Trial:3 - Optimized Method 
(Codeine phosphate and Triprolidine hydrochloride) 
 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Resolution Assay 
Value 
(%) 
Codeine 
phosphate 2.826 812.508 0.74 3892 0.00 99.5 
Triprolidine 
hydrochloride 
12.436 696.607 0.59 5182 22.0 99.9 
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CHAPTER - VII 
 
METHOD VALIDATION 
 
7.1 Validation: 
 According to the ICH guidelines, Method Validation is the process used to 
confirm that the analytical procedure employed for a specific test is suitable for 
its intended use. “Establishing documented evidence, which provides a high 
degree of assurance that a specific activity will consistently produce a desired 
result or product meeting its predetermined specification and quality, reliability 
and consistency of analytical results. It is an integral part of any good analytical 
practice. 
 Such validation analytical method for qualitative and quantitative testing of the 
drug molecule assume greater importance when they are employed to generate 
quality and safety compliance data during development, pre-formulation studies 
and post approval of drug products. 
7.2 Validation Parameters: 
 Typical analytical parameters used in assay validation include, 
A) System Suitability  
B) Accuracy  
C) Precision 
D) Specificity  
E) Linearity 
F) Robustness  
G) Ruggedness 
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A) System Suitability: 
 System suitability testing is an integral part of many analytical procedures. The 
tests are based on the concept that the equipment, electronics, analytical 
operations and samples to be analytical constitute an integral system that can be 
evaluated as such.  
 System suitability test parameters to be established for a particular procedure 
depend on the type of procedure being validated and the parameters like retention 
time, area, tailing factor and theoretical plates are determined and the 
chromatogram for the system suitability is shown in Figure No. 14 and the 
results obtained were tabulated as shown in Table No. 9 to 10. 
 Acceptance Criteria: 
 % RSD of peak area should NMT 2.0. 
 The tailing factor for Codeine phosphate and Triprolidine hydrochloride peak 
should NMT 2.0. 
 The column efficiency for Codeine phosphate and Triprolidine hydrochloride 
should NLT 3000 theoretical plates. 
B) Accuracy: 
 The accuracy of an analytical procedure express the closeness of agreement 
between the value which is accepted either as a conventional true value or an 
accepted reference value and the value found. This is sometimes termed trueness. 
 Accuracy should be reported as percent recovery by the assay of known added 
amount of analytes in the sample or as the difference between the mean and the 
accepted true value together with the confidence intervals. Accuracy may be 
inferred once precision, linearity and specificity have been established.  
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 Procedure: 
 Accurately weigh and transfer 200 µg of Codeine phosphate and 25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric flask, 
add about 70 ml of diluents and sonicate to dissolve it completely and make 
volume up to the mark with the same solvent (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml volumetric flask 
and dilute up to the mark with diluents. Mix well and filter through 0.22 µm 
filter (Membrane filter).         
 Preparation of 50% Sample Solution: 
 Accurately weigh and transfer 100 µg of Codeine phosphate and 15 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask, add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to mark with the same solvent (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter). 
 Preparation of 100% Sample Solution: 
 Accurately weigh and transfer 200 µg of Codeine phosphate and 25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to the mark with the same solvent  (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter).   
 
CHAPTER - VII                                                                            Method Validation                                                          
 
69 
 Preparation of 150% Sample Solution: 
 Accurately weigh and transfer 300 µg of Codeine phosphate and 30 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask add about 70 ml of diluents and sonicate to dissolve it completely 
and volume up to mark with the same solvent (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter).  
 Inject 20 µl of placebo and standard solution of accuracy-50%, accuracy-100% 
and accuracy-150% solutions into HPLC. Now calculate the amount obtained 
and amount added for Codeine phosphate and Triprolidine hydrochloride 
samples. Calculate the concentration in µg/ml in the spiked placebo in all the 
above cases by comparing with the standard solution. Calculate the individual 
recovery and mean recovery values. The chromatogram for the accuracy is 
shown in Figure No. 15 to 17 and the results obtained were tabulated 
(including overall Mean, SD and % RSD) as shown in Table No. 11 to 14. 
Also % recovery study results for Codeine phosphate and Triprolidine 
hydrochloride are shown in Table No. 15.  
 Calculation:      
                                                Amount recovered 
                              % Recovery = ------------------------------- x100     
                                                       Actual amount added      
 Acceptance Criteria: 
 % recovery in all the cases should be between 100±2 %. 
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C) Precision: 
 The precision of an analytical method is the degree of agreement among 
individual test results obtained when the method is applied to multiple sampling 
of a homogenous sample. 
 Precision may be considered at three levels: repeatability, intermediate precision 
and reproducibility. Precision should be investigated using homogeneous, 
authentic samples using a minimum of 6 determinations at 100 percent of the test 
concentration. The precision of an analytical procedure is usually expressed as 
the variance, standard deviation or coefficient of variation of a series of 
measurements. 
 Procedure: 
i) System Precision: 
Six replicate injections of standard solution were injected into the HPLC system. 
 Preparation of Standard Solution (100 µg/ml): 
 Accurately weigh and transfer 200 µg of Codeine phosphate and 25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask, add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to the mark with the same solvent (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter). 
 Inject 20 µl of the blank solution and six replicate injections of standard 
solution of 100 µg/ml and calculate the % RSD for the area of six replicate 
injections. The chromatogram for system precision including blank is 
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shown in Figure No.18 to 19 and the results obtained were tabulated as 
shown in Table No. 16. 
ii) Method Precision: 
Six replicate injections of sample solution were injected into the HPLC system. 
 Preparation of Sample Solution (100 µg/ml): 
 Accurately pipette out 5 ml of the sample into a 100 ml volumetric flask 
and 70 ml of diluents was added and mixed well and make volume up to 
the mark with diluents. Mix well and filter through 0.22 µm filter 
(Membrane filter). 
 Inject 20 µl of the blank solution and six replicate injections of sample 
solution of 100 µg/ml and calculate the % RSD for the area of six 
replicate injections. The chromatogram for method precision including 
blank is shown in Figure No. 18 and Figure No. 20 to 25 and the results 
obtained were tabulated (including overall Mean, SD and % RSD) as 
shown in Table No. 17 to 23. 
 Calculation:      
% RSD = (σ/µ)*100 
 Acceptance Criteria: 
 % RSD for the area of Codeine phosphate and Triprolidine hydrochloride from 
the sample chromatogram should NMT 1.0. 
D) Specificity: 
 The specificity of the method corresponds to the non-interaction of the placebo 
with that of the active particle. Typically these might include impurities, 
degradants, matrix etc.  
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 Procedure: 
 Preparation of Standard Solution:  
 Accurately weigh and transfer 200 µg of Codeine phosphate and 25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask, add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to the mark with the same solvent (Stock solution). 
 Further pipette 5ml of the above stock solution into a 25 ml volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter). Inject 20 µl of blank solution into the 
HPLC system and observe chromatogram. 
 Inject 20 µl of standard solution for six times into the HPLC system and 
compare the chromatogram visually and check for any interference. 
Calculate the % RSD for the area of six replicate injections. The 
chromatogram for specificity including blank is shown in Figure No. 26 
and Figure No. 27 to 32 and the results obtained were tabulated 
(including overall Mean, SD and % RSD) as shown in                       
Table No. 24 to 30. 
 Calculation:      
% RSD = (σ/µ)*100 
 Acceptance Criteria: 
 There should not be any peak in the blank and placebo solution run at the 
retention time corresponding to Codeine phosphate and Triprolidine 
hydrochloride as in standard run. 
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E) Linearity: 
 The linearity of an analytical procedure is its ability (within a given range) to 
obtain test results which are directly proportional to the concentration (amount) 
of analyte in the sample. The procedure used for linearity was carried out as per 
ICH Q2 (R1) guidelines. 
 A linear relationship should be evaluated across the range of the analytical 
procedure by visual inspection of a plot of signals as a function of analyte 
concentration or content. If there is a linear relationship, test results should be 
evaluated by appropriate statistical methods, for example, by calculated of 
correlation coefficient, y-intercept, slope of the regression line and residual sum 
of squares. A plot of the data should be included. For the establishment of 
linearity, a minimum of five concentrations is recommended. 
 Procedure: 
 Preparation of Standard Solution:  
 Accurately weigh and transfer 200 µg of Codeine phosphate and  25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask, add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to the mark with the same solvent (Stock solution).  
 Preparation of Sample Solution: 
 From the above stock solution, pipette out 5.0, 7.5, 10.0, 12.5 and 15.0 ml 
respectively into individual 50 ml of volumetric flasks and dilute up to the 
mark with diluents to prepare 50, 75, 100, 125 and 150 µg/ml of sample 
solution respectively. Mix well and filter through 0.22 µm filter 
(Membrane filter). 
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 Inject 20 µl of blank solution and standard solutions into the 
chromatographic system and measure the peak area. Plot a graph of peak 
area versus concentration (on x-axis concentration and on y-axis peak 
area) and calculate the correlation coefficient. The chromatogram for 
linearity including overlay is shown in Figure No. 33 to 40 and the results 
obtained were tabulated as shown in Table No. 31 to 37. 
 Calculation:      
 
               Regression line (y) = mx+c 
                                            (Where, m = slope, c = y-intercept) 
 Acceptance Criteria: 
 Correlation coefficient should NLT 0.995. 
F) Robustness: 
 The robustness of an analytical procedure is a measure of its capacity to remain 
unaffected by small, but deliberate variations in method parameters and provides 
an indication of its reliability during normal usage. The procedure used for 
robustness was carried out as per ICH Q2 (R1) Guidelines. 
 To perform the robustness of the method, deliberate change the conditions like 
flow rate as well as pH of buffer solution in mobile phase and to evaluate the 
impact on the method. 
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 Procedure: 
 Preparation of Standard Solution (100 µg/ml): 
 Accurately weigh and transfer 200 µg of Codeine phosphate and 25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask, add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to the mark with the same solvent (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml of volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter). 
 Inject 20 µl of the blank solution and the standard solution of 100 µg/ml 
for five times and analyzed using varied flow rates (1.2 ml and 1.4 ml) 
along with optimized method flow rate and the pH of buffer solution in 
mobile phase was varied at +/- 0.1 from the normal pH of 2.3. Finally 
calculate the % RSD for the area of five replicate injections. The 
chromatogram for robustness including blank is shown in Figure No. 41 
and Figure No. 42 to 53 and the results obtained were tabulated 
(including overall Mean, SD and % RSD) as shown in                       
Table No. 38 to 50. 
 Calculation:      
% RSD = (σ/µ)*100 
 Acceptance Criteria: 
 The effect of change in the flow rate and pH of buffer solution in mobile 
phase, % RSD for the area of Codeine phosphate and Triprolidine 
hydrochloride should NMT 1.0. 
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G) Ruggedness: 
 Ruggedness is the degree of reproducibility of results obtained by the analysis of 
the same sample under a variety of normal test conditions i.e. different analysts, 
laboratories, instruments, reagents, assay temperatures, small variations in mobile 
phase, different days etc. (i.e. from laboratory to laboratory, from analyst to 
analyst). 
 Ruggedness of the current method was demonstrated by analyzing two samples 
of syrup formulation by two different analysts in the same laboratory.  
 Procedure: 
 Preparation of Standard Solution (100 µg/ml): 
 Accurately weigh and transfer 200 µg of Codeine phosphate and 25 µg of 
Triprolidine hydrochloride working standards into a 100 ml volumetric 
flask, add about 70 ml of diluents and sonicate to dissolve it completely 
and make volume up to the mark with the same solvent (Stock solution). 
 Further pipette 5 ml of the above stock solution into a 25 ml of volumetric 
flask and dilute up to the mark with diluents. Mix well and filter through 
0.22 µm filter (Membrane filter). 
 Inject 20 µl of the blank solution and the standard solution of 100 µg/ml 
for six times and analyzed by two different analysts in the same 
laboratory. Finally calculate the % RSD for the area of twelve replicate 
injections. The chromatogram for ruggedness including blank is shown in 
Figure No. 54 and Figure No. 55 to 56 and the results obtained were 
tabulated (including overall Mean, SD and % RSD) as shown in        
Table No. 51 to 54. 
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 Calculation:      
% RSD = (σ/µ)*100 
 Acceptance Criteria: 
 % RSD for the area of Codeine phosphate and Triprolidine hydrochloride 
should NMT 1.0. 
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 CHAPTER - VIII 
 
RESULTS AND DISCUSSION 
 
8.1 System Suitability: 
Figure No. 14. Chromatogram of System Suitability 
 
Table No. 9. Results of System Suitability (Codeine phosphate) 
No. of       
Injection 
RT Area 
Tailing      
Factor 
Theoretical 
Plates 
1 2.827 825335 0.74 3892 
2 2.823 825338 0.73 3795 
3 2.825 825330 0.73 3852 
4 2.822 825337 0.75 3845 
5 2.826 825333 0.72 3862 
6 2.828 824388 0.71 3895 
Mean 2.8251 825176.8 0.73 3856.833 
SD 0.0023 386.4585 0.014 36.62467 
% RSD 0.091 0.04 1.9 0.9496 
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Table No. 10. Results of System Suitability (Triprolidine hydrochloride) 
No. of       
Injection 
RT Area 
Tailing      
Factor 
Theoretical 
Plates 
1 12.437 696605    0.66 5185 
2 12.432 696573 0.65 5179 
3 12.435 695605 0.67 5183 
4 12.433 695793 0.64 5181 
5 12.438 694599 0.67 5178 
6 12.436 696703 0.65 5182 
Mean 12.435 695988 0.656 5186 
SD 0.0023 755.2234 0.0121 5.5136 
% RSD 0.018 0.118 1.8 0.1 
 
8.2 Accuracy: 
 Figure No. 15. Chromatogram of Accuracy (50% Spike Solution) 
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Table No. 11. Results of Accuracy (50% Spike Solution) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.826 865929 0.73 4817 
Triprolidine 
hydrochloride 
12.485 694297 0.61 5184 
 
Figure No. 16. Chromatogram of Accuracy (100% Spike Solution) 
 
 
Table No. 12. Results of Accuracy (100% Spike Solution) 
 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.829 865934 0.73 4320 
Triprolidine 
hydrochloride 
12.433 694296 0.61 5181 
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Figure No. 17. Chromatogram of Accuracy (150% Spike Solution) 
 
Table No. 13. Results of Accuracy (150% Spike Solution) 
 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 2.828 865933 0.74 4314 
Triprolidine 
hydrochloride 12.431 694294 0.60 5185 
 
Table No. 14. Results of Accuracy (Overall Mean, SD, % RSD for  
                      Codeine phosphate and Triprolidine hydrochloride) 
 
Name RT Area 
Tailing 
Factor 
Theoretical 
Plates 
 
Codeine 
phosphate 
Mean 2.8486 865932 0.74 3873.17 
SD 0.0025 3.7416 0.008 41.5953 
% RSD 0.8 0.0004 1.081 1.0 
 
Triprolidine 
hydrochloride 
Mean 13.6585 694295.6 0.6216 4904 
SD 0.00207 2.16 0.0116 4. 979 
% RSD 0.014 0.0002 1.8 0.1 
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Table No. 15. Results of % Recovery for Codeine phosphate and 
                                      Triprolidine hydrochloride 
 
Injection 
Sample 
Spike 
Level 
(%) 
Amount 
Present 
(µg) 
Amount 
Recovered 
(µg) 
% 
Recovered 
Mean 
Recovery 
(%) 
Accep. 
Criteria 
(%) 
Codeine 
phosphate 
50 100 99.8 99.8 
99.8 100 ± 2.0 100 200 199.8 99.9 
150 300 300.07 99.8 
Triprolidine 
HCl 
50 15 15 100.0 
100.0 100 ± 2.0 100 25 25 100.0 
150 35 35 100.0 
 
8.3 Precision: 
Figure No. 18. Chromatogram of Precision (Blank) 
 
 
 
 
CHAPTER - VIII                                                                     Results and Discussion                                                         
 
83 
i) System Precision: 
Figure No. 19. Chromatogram of System Precision (Standard) 
 
 
 
Table No. 16. Results of System Precision (Standard) 
 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.826 865929 0.73 4317 
Triprolidine 
hydrochloride 
12.465 694298 0.60 5184 
 
ii) Method Precision: 
 
Figure No. 20. Chromatogram of Method Precision (Sample - 1) 
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Table No. 17. Results of Method Precision (Sample - 1) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.875 865909 0.73 3858 
Triprolidine 
hydrochloride 
13.857 694289 0.62 4898 
 
Figure No. 21. Chromatogram of Method Precision (Sample - 2) 
 
Table No. 18. Results of Method Precision (Sample - 2) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.873 865912 0.75 3857 
Triprolidine 
hydrochloride 
13.856 694292 0.63 4894 
 
 
 
 
CHAPTER - VIII                                                                     Results and Discussion                                                         
 
85 
Figure No. 22. Chromatogram of Method Precision (Sample - 3) 
Table No. 19. Results of Method Precision (Sample - 3) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.875 865918 0.73 3056 
Triprolidine 
hydrochloride 
13.859 694295 0.62 4893 
 
Figure No. 23. Chromatogram of Method Precision (Sample - 4) 
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Table No. 20. Results of Method Precision (Sample - 4) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.879 865911 0.74 3859 
Triprolidine 
hydrochloride 
13.858 694293 0.64 4899 
  
Figure No. 24. Chromatogram of Method Precision (Sample - 5) 
 
Table No. 21. Results of Method Precision (Sample - 5) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.876 865908 0.75 3855 
Triprolidine 
hydrochloride 
13.862 694296 0.61 4896 
 
 
 
 
CHAPTER - VIII                                                                     Results and Discussion                                                         
 
87 
Figure No. 25. Chromatogram of Method Precision (Sample - 6) 
 
Table No. 22. Results of Method Precision (Sample - 6) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.878 865919 0.73 3854 
Triprolidine 
hydrochloride 
13.859 694294 0.61 4897 
 
Table No. 23. Results of Method Precision (Overall Mean, SD, % RSD for  
        Codeine phosphate and Triprolidine hydrochloride) 
 
Name RT Area 
Tailing 
Factor 
Theoretical 
Plates 
 
Codeine 
phosphate 
Mean 2.8486 865935 0.74 3873.17 
SD 0.0025 2.984 0.008 41.5953 
% RSD 0.8 0.00034 1.081 0.1 
 
Triprolidine 
hydrochloride 
Mean 13.6585 694291 0.6216 4904 
SD 0.00207 2.5819 0.0116 4. 979 
% RSD 0.014 0.00037 1.8 0.1 
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8.4 Specificity: 
Figure No. 26. Chromatogram of Specificity (Blank) 
 
Figure No. 27. Chromatogram of Specificity (Standard - 1) 
 
Table No. 24. Results of Specificity (Standard - 1) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.835 812508 0.71 3782 
Triprolidine 
hydrochloride 
13.907 696610 0.60 4867 
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Figure No. 28. Chromatogram of Specificity (Standard - 2) 
 
Table No. 25. Results of Specificity (Standard - 2) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.833 812619 0.72 3785 
Triprolidine 
hydrochloride 
13.905 696605 0.61 4863 
 
Figure No. 29. Chromatogram of Specificity (Standard - 3) 
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Table No. 26. Results of Specificity (Standard - 3) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.839 812512 0.70 3784 
Triprolidine 
hydrochloride 
13.903 696612 0.61 4865 
 
Figure No. 30. Chromatogram of Specificity (Standard - 4) 
 
Table No. 27. Results of Specificity (Standard - 4) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.837 812613 0.71 3783 
Triprolidine 
hydrochloride 
13.905 696612 0.60 4862 
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Figure No. 31. Chromatogram of Specificity (Standard - 5) 
 
Table No. 28. Results of Specificity (Standard - 5) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.836 812509 0.70 3782 
Triprolidine 
hydrochloride 
13.906 696609 0.61 4863 
 
Figure No. 32. Chromatogram of Specificity (Standard - 6) 
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Table No. 29. Results of Specificity (Standard - 6) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.832 812505 0.71 3781 
Triprolidine 
hydrochloride 
13.904 696603 0.60 4860 
 
Table No. 30. Results of Specificity (Overall Mean, SD, % RSD for  
                    Codeine phosphate and Triprolidine hydrochloride) 
 
Name RT Area 
Tailing 
Factor 
Theoretical 
Plates 
 
Codeine 
phosphate 
Mean 2.8353 812544.3 0.70833 3782.833 
SD 0.0025 55.59027 0.00752 1.471 
% RSD 0.088 0.006 1.0 0.03 
 
Triprolidine 
hydrochloride 
Mean 13.905 696607.8 0.605 4863 
SD 0.0014 3.3115 0.005477 1.4142 
% RSD 0.01 0.0004 0.90 0.02 
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8.5 Linearity:   
Figure No. 33. Chromatogram of Linearity - 1 (50 µg/ml) 
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Table No. 31. Results of Linearity - 1 (50 µg/ml) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.289 294820 0.73 3793 
Triprolidine 
hydrochloride 
13.907 524063 0.61 4851 
 
Figure No. 34. Chromatogram of Linearity - 2 (75 µg/ml) 
 
 
CHAPTER - VIII                                                                     Results and Discussion                                                         
 
94 
Table No. 32. Results of Linearity - 2 (75 µg/ml) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.287 446999 0.72 3858 
Triprolidine 
hydrochloride 
13.877 792940 0.61 4898 
 
Figure No. 35. Chromatogram of Linearity - 3 (100 µg/ml) 
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Table No. 33. Results of Linearity - 3 (100 µg/ml) 
 Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.295 595115 0.73 3851 
Triprolidine 
hydrochloride 
13.825 1063971 0.60 5004 
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Figure No. 36. Chromatogram of Linearity - 4 (125 µg/ml) 
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Table No. 34. Results of Linearity - 4 (125 µg/ml) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.296 748334 0.74 3798 
Triprolidine 
hydrochloride 
13.790 1342834 0.60 4906 
 
Figure No. 37. Chromatogram of Linearity - 5 (150 µg/ml) 
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Table No. 35. Results of Linearity - 5 (150 µg/ml) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.289 898406 0.74 3770 
Triprolidine 
hydrochloride 
13.744 1618163 0.60 4874 
 
Figure No. 38. Chromatogram of Overlay of Linearity 1 - 5 (50 to 150 µg/ml) 
 
Figure No. 39. Chromatogram of Linearity Level 1 - 5 (50 to 150 µg/ml)  
                                 for Codeine phosphate 
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Table No. 36. Results of Linearity Level 1 - 5 (50 to 150 µg/ml)  
                                       for Codeine phosphate  
 
Linearity 
level 
Concentration (µg/ml) Area 
1 50 294820 
2 75 446999 
3 100 595115 
4 125 748334 
5 150 898406 
Correlation Coefficient 0.9999901 
 
Figure No. 40. Chromatogram of Linearity Level 1 - 5 (50 to 150 µg/ml) 
                                 for Triprolidne hydrochloride 
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Table No. 37. Results of Linearity Level 1 - 5 (50 to 150 µg/ml) 
                                   for Triprolidne hydrochloride 
 
Linearity 
level 
Concentration (µg/ml) Area 
1 50  524063 
2 75 792940 
3 100 1063971 
4 125 1342834 
5 150  1618163 
Correlation Coefficient 0.999974 
 
8.6 Robustness: 
      Figure No. 41. Chromatogram of Robustness (Blank) 
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i) Flow Rate Variation - 1 (1.2 ml/min): 
Figure No. 42. Chromatogram of Robustness - Standard Solution 1  
 (Flow Rate - 1.2 ml/min) 
 
Table No. 38. Results of Robustness - Standard Solution 1  
           (Flow Rate - 1.2 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.292 920909 0.74 3757 
Triprolidine 
hydrochloride 
13.921 614097 0.63 4862 
 
Figure No. 43. Chromatogram of Robustness - Standard Solution 2  
 (Flow Rate - 1.2 ml/min) 
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Table No. 39. Results of Robustness - Standard Solution 2  
           (Flow Rate - 1.2 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.297 920905 0.72 3752 
Triprolidine 
hydrochloride 
13.925 617095 0.67 4865 
 
Figure No. 44. Chromatogram of Robustness - Standard Solution 3  
 (Flow Rate - 1.2 ml/min) 
 
Table No. 40. Results of Robustness - Standard Solution 3  
           (Flow Rate - 1.2 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.289 920909 0.71 3715 
Triprolidine 
hydrochloride 
13.929 614093 0.63 4869 
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Figure No. 45. Chromatogram of Robustness - Standard Solution 4 
 (Flow Rate - 1.2 ml/min) 
 
Table No. 41. Results of Robustness - Standard Solution 4  
           (Flow Rate - 1.2 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.282 920907 0.73 3719 
Triprolidine 
hydrochloride 
13.942 615099 0.64 4867 
 
Figure No. 46. Chromatogram of Robustness - Standard Solution 5  
 (Flow Rate - 1.2 ml/min)  
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Table No. 42. Results of Robustness - Standard Solution 5  
           (Flow Rate - 1.2 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.283 9250904 0.73 3758 
Triprolidine 
hydrochloride 
13.928 614096 0.64 4862 
 
ii) Flow Rate Variation - 2 (1.4 ml/min): 
Figure No. 47. Chromatogram of Robustness - Standard Solution 1 
             (Flow Rate - 1.4 ml/min) 
 
Table No. 43. Results of Robustness - Standard Solution 1  
           (Flow Rate - 1.4 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
1.985 829932 0.73 3894 
Triprolidine 
hydrochloride 
13.949 624587 0.60 4865 
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Figure No. 48. Chromatogram of Robustness - Standard Solution 2 
             (Flow Rate - 1.4 ml/min) 
 
Table No. 44. Results of Robustness - Standard Solution 2  
           (Flow Rate - 1.4 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
1.983 825735 0.74 3899 
Triprolidine 
hydrochloride 
13.945 624289 0.61 4877 
 
Figure No. 49. Chromatogram of Robustness - Standard Solution 3 
             (Flow Rate - 1.4 ml/min) 
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Table No. 45. Results of Robustness - Standard Solution 3  
           (Flow Rate - 1.4 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
1.989 825939 0.72 3897 
Triprolidine 
hydrochloride 
13.943 624786 0.61 4878 
 
Figure No. 50. Chromatogram of Robustness - Standard Solution 4 
             (Flow Rate - 1.4 ml/min) 
 
Table No. 46. Results of Robustness - Standard Solution 4  
           (Flow Rate - 1.4 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
1.987 825330 0.74 3896 
Triprolidine 
hydrochloride 
13.948 624282 0.60 4862 
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Figure No. 51. Chromatogram of Robustness - Standard Solution 5 
             (Flow Rate - 1.4 ml/min) 
 
Table No. 47. Results of Robustness - Standard Solution 5  
            (Flow Rate - 1.4 ml/min) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
1.982 825934 0.76 3894 
Triprolidine 
hydrochloride 
13.947 624383 0.60 4871 
 
iii) pH Variation - 1 (2.2): 
Figure No. 52. Chromatogram of Robustness - Standard Solution (pH - 2.2) 
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Table No. 48. Results of Robustness - Standard Solution (pH - 2.2) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.287 865928 0.74 3799 
Triprolidine 
hydrochloride 
13.827 604285 0.65 4859 
 
iv) pH Variation - 2 (2.4): 
Figure No. 53. Chromatogram of Robustness - Standard Solution (pH - 2.4) 
 
Table No. 49. Results of Robustness - Standard Solution (pH - 2.4) 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.289 865924 0.73 3795 
Triprolidine 
hydrochloride 
13.829 604287 0.64 4855 
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Table No. 50. Results of Robustness - Flow Rate Variation/Standard Solution 
                            1 to 5 (Overall Mean, SD, % RSD for Codeine phosphate and  
   Triprolidine hydrochloride) 
 
Flow Rate Variation RT Area 
Tailing 
Factor 
Theoretical 
Plates 
Flow Rate - 1.2 ml/min     
Codeine 
phosphate 
Mean 2.2886 921906.8 0.726 3780.2 
SD 0.0062 24.503 0.0114 37.7001 
% RSD 0.2 0.24 1.5 1.0 
 
Triprolidine 
hydrochloride 
Mean 13.9296 1303.842 0.63 4865 
SD 0.0079 614898 0.0081 3.0822 
% RSD 0.05 0.21 1.2 0.06 
Flow Rate - 1.4 ml/min     
Codeine 
phosphate 
Mean 1.9854 826574 0.738 3896 
SD 0.0026 1893.43 0.0148 2.1213 
% RSD 0.13 0.22 2.0 0.05 
Triprolidine 
hydrochloride 
Mean 13.9464 624465.4 0.604 4869 
SD 0.0021 217.43 0.0054 6.1886 
% RSD 0.017 0.03 0.9 0.12 
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8.7 Ruggedness: 
Figure No. 54. Chromatogram of Ruggedness (Blank) 
 
 
Figure No. 55. Chromatogram of Ruggedness - Day 1 (Analyst - 1) for  
           Codeine phosphate and Triprolidine hydrochloride 
 
 
Table No. 51. Results of Ruggedness - Day 1 (Analyst - 1) for  
                              Codeine phosphate and Triprolidine hydrochloride 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.239 816151 0.73 3795 
Triprolidine 
hydrochloride 
13.825 623254 0.64 4863 
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Figure No. 56. Chromatogram of Ruggedness - Day 2 (Analyst - 2) for  
           Codeine phosphate and Triprolidine hydrochloride 
 
Table No. 52. Results of Ruggedness - Day 2 (Analyst - 2) for  
                              Codeine phosphate and Triprolidine hydrochloride 
Name RT Area 
Tailing      
Factor 
Theoretical 
Plates 
Codeine 
phosphate 
2.235 816152 0.75 3794 
Triprolidine 
hydrochloride 
13.822 623254 0.63 4861 
 
Table No. 53. Results of Ruggedness - Day 1 & 2 (Analyst - 1) for  
                       Codeine phosphate and Triprolidine hydrochloride 
 
Analyst - 1 
S. No. 
Day - 1 Day - 2 
Codeine 
phosphate 
Triprolidine 
hydrochloride 
Codeine 
phosphate 
Triprolidine 
hydrochloride 
1 816151 623254 824035 625842 
2 818636 624792 822456 624689 
3 816152 624434 826945 623688 
Mean 816979.6 624160 824478.6 624739.6 
SD 2028.58 1138.12 3220.37 1524.37 
% RSD 0.24 0.1 0.3 0.2 
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Table No. 54. Results of Ruggedness - Day 1 & 2 (Analyst - 2) for  
                       Codeine phosphate and Triprolidine hydrochloride 
 
Analyst - 2 
S. No. 
Day - 1 Day - 2 
Codeine 
phosphate 
Triprolidine 
hydrochloride 
Codeine 
phosphate 
Triprolidine 
hydrochloride 
1 820077 624039 816152 623254 
2 827463 624578 827628 628846 
3 824628 624158 821968 626904 
Mean 824056 624258.3 821916 62634.6 
SD 3456.97 400.45 8115.00 4015.15 
% RSD 0.4 0.06 0.9 0.6 
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CHAPTER - IX 
 
SUMMARY AND CONCLUSION 
 
 Development of new analytical methods for the determination of drugs in 
pharmaceutical dosage forms is more important in pharmacokinetic, toxicological 
and biological studies. Today pharmaceutical analysis entails much more than the 
analysis of active pharmaceutical ingredients or the formulated product. The 
pharmaceutical industry is under increased scrutiny from the government and the 
public interested groups to contain costs and at consistently deliver to market safe, 
efficacious product that fulfill unmet medical needs. 
 The pharmaceutical analyst plays a major role in assuring identity, safety, efficacy, 
purity and quality of a drug product. The need for pharmaceutical analysis is 
driven largely by regulatory requirements. The commonly used tests of 
pharmaceutical analysis generally entail compendia testing method development, 
setting specifications and method validation. 
 Analytical testing is one of the more interesting ways for scientists to take part in 
quality process by providing actual data on the identity, content and purity of the 
drug products. New methods are now being developed with a great deal of 
consideration to worldwide harmonization. As a result, new products can be 
assured to have comparable quality and can be brought to international markets 
faster. 
 In the present study a new RP-HPLC method was developed for the simultaneous 
determination of Codeine phosphate (CP) and Triprolidine hydrochloride (TH) in 
cough syrup formulation. A sample preparation is very simple and the analysis 
time is short. 
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 The analysis is resolved by using an Inersustain C18 (250 x 4.6 mm, 5µ) column, 
in isocratic mode, with mobile phase containing buffer (pH 3.0 with 
Orthophosphoric acid) and methanol in the final ratio of 55:45 v/v was used. The 
flow rate was 1.0 ml/min and the analyte was monitored at 280 nm. The retention 
time for Codeine phosphate and Triprolidine hydrochloride were about 2.8 min. 
and 12.4 min. respectively. 
 The method was validated (As per ICH guidelines) for System suitability, 
Accuracy, Precision, Specificity, Linearity, Robustness and Ruggedness. The 
overall validation summary was tabulated as shown in Table No. 55. 
 System Suitability: From the observation it was concluded that the method 
passes system suitability. 
 Accuracy (Recovery Studies): The % recovery results were found with in 
the limits. It was concluded that the test method has an acceptable level of 
accuracy from 50% to 150% of target concentration. 
 Precision: Test results for Codeine phosphate and Triprolidine 
hydrochloride were shown that the % RSD of peak area was found within 
the limits. Hence, the method was precise. 
 Specificity: It was concluded that there is no interference due to blank and 
placebo solution. Hence the method is specific and the results were found 
to be complying with the acceptance criteria. 
 Linearity: The correlation coefficient values were found within the 
acceptance limits. 
 Robustness: The effect of change in the flow rate and pH of buffer solution 
in mobile phase, it was concluded that the % RSD of peak area was found 
within the limits. Hence, the method was robust. 
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 Ruggedness: The % RSD of peak area was found within the limits. It was 
concluded that the test method is rugged. 
Table No. 55. Validation Summary 
S. No. Parameter Experiment 
Acceptance 
Criteria 
Observed Results 
CP TH 
1 System 
Suitability 
Peak area 
 
 
 
 
Tailing 
factor 
 
 
 
Theoretical 
plates 
 % RSD of 
peak area 
should NMT 
2.0. 
 
 The tailing 
factor for CP 
and TH should 
NMT 2.0. 
 
 The column 
efficiency for 
CP and TH 
should NLT 
3000 
theoretical 
plates. 
0.04 
 
 
 
 
 
1.9 
 
 
 
3856 
 
 
0.11 
 
 
 
 
 
1.8 
 
 
 
5186 
 
 
2 Accuracy % recovery  % recovery in 
all the cases 
should be 
between 
100±2. 
99.8 % 100 % 
 
 
3 Precision Peak area  % RSD of 
peak area 
should NMT 
1.0. 
0.0003 % 0.0003 % 
 
4 Specificity Interference  There should 
not be any 
interference in 
the blank and 
placebo 
solution. 
No 
interference 
No 
interference 
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5 Linearity Correlation 
coefficient 
 Correlation 
coefficient 
should NLT 
0.995. 
0.999 0.999 
 
6 Robustness Peak area 
 
 
Flow rate 
variation: 
 
Flow Rate - 
1.2 ml/min 
 
Flow Rate - 
1.4 ml/min 
 % RSD of 
peak area 
should NMT 
1.0. 
 
 
 
 
 
 
0.24 
 
 
0.22 
 
 
 
 
 
 
0.21 
 
 
0.03 
7 Ruggedness Peak area 
 
 
Analyst 1: 
 
Day - 1 
 
Day - 2 
 
Analyst 2: 
 
Day - 1 
 
Day - 2 
 
 % RSD of 
peak area 
should NMT 
1.0. 
 
 
 
 
 
0.24 
 
0.3 
 
 
 
0.4 
 
0.9 
 
 
 
 
 
 
0.1 
 
0.2 
 
 
 
0.06 
 
0.6 
 
 Finally it was concluded that the proposed method are sensitive, accurate, precise, 
simple and reproducible and can be used for the simultaneous determination of 
Codeine phosphate and Triprolidine hydrochloride in cough syrup formulation by 
RP-HPLC. 
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